http://pharmadispatch.com/news/doha-legal-advice-pbac-not-able-to-impose-conditions-on-recommen 2014-11-14T17:00:01+11:00 http://pharmadispatch.com/news/a-final-dispatch-for-2013-outcomes-indicate-a-new-approach-by-th 2014-01-01T11:36:54+11:00 http://pharmadispatch.com/news/mixed-views-on-new-pbac-approach 2014-01-13T21:08:06+11:00 http://pharmadispatch.com/news/another-busy-pbac-meeting 2014-01-13T21:07:33+11:00 http://pharmadispatch.com/news/time-for-sector-to-unite-and-get-on-the-front-foot 2014-01-13T21:07:02+11:00 http://pharmadispatch.com/news/end-game-nears-in-gliptin-pricing-controversy 2014-01-13T21:08:52+11:00 http://pharmadispatch.com/news/time-the-enemy-for-grattan 2014-01-13T21:08:30+11:00 http://pharmadispatch.com/news/patients-want-compassion-on-meningococcal-vaccine 2014-01-15T21:01:34+11:00 http://pharmadispatch.com/news/pbac-not-directed-to-deliver-more-positive-recommendations 2014-01-14T20:59:46+11:00 http://pharmadispatch.com/news/benefits-of-vitamin-d-for-bone-health-indisputable-says-asmi 2014-01-14T20:59:24+11:00 http://pharmadispatch.com/news/pharmacy-groups-unite-for-flu-vaccine-pilot-in-qld 2014-01-14T20:59:01+11:00 http://pharmadispatch.com/news/ex-pfizer-exec-takes-the-helm-at-shire-australia 2014-01-15T21:00:29+11:00 http://pharmadispatch.com/news/commission-of-audit-front-senate-committee-today 2014-01-15T20:59:40+11:00 http://pharmadispatch.com/news/newman-rejects-ama-call-to-stop-pharmacy-flu-vax-trial 2014-01-16T21:05:48+11:00 http://pharmadispatch.com/news/all-options-on-the-table-commission-tells-senate 2014-01-16T21:06:41+11:00 http://pharmadispatch.com/news/az-upgrades-forecast-on-pipeline-and-diabetes-deal 2014-01-16T21:05:21+11:00 http://pharmadispatch.com/news/robb-highlights-amgen-and-csl-in-speech-promoting-tpp 2014-01-16T21:07:03+11:00 http://pharmadispatch.com/news/abbvies-odoherty-pbs-sustainable-for-government-but-not-industry 2014-01-20T20:59:01+11:00 http://pharmadispatch.com/news/di-natale-defends-commission-of-audit-inquiry 2014-01-17T20:57:23+11:00 http://pharmadispatch.com/news/new-guidelines-more-user-friendly-but-more-change-to-come 2014-01-17T20:57:33+11:00 http://pharmadispatch.com/news/vaccines-in-rooms-full-of-toilet-paper-claims-ama 2014-01-17T20:57:45+11:00 http://pharmadispatch.com/news/pbs-claims-would-be-funny-if-they-werent-so-serious 2014-01-20T20:58:57+11:00 http://pharmadispatch.com/news/michael-wonder-breaks-down-the-march-pbac-agenda 2014-01-20T20:59:27+11:00 http://pharmadispatch.com/news/international-comparisons-over-simplify-and-certain-to-mislead 2014-01-20T20:59:11+11:00 http://pharmadispatch.com/news/industry-engaged-in-a-satanic-plot 2014-01-20T20:58:39+11:00 http://pharmadispatch.com/news/msd-stands-its-ground-on-januvia-pricing 2014-01-21T21:13:17+11:00 http://pharmadispatch.com/news/in-the-end-it-comes-down-to-the-minister 2014-01-21T21:13:03+11:00 http://pharmadispatch.com/news/petition-urges-funding-for-soliris 2014-01-22T21:08:01+11:00 http://pharmadispatch.com/news/commission-of-audit-gets-an-extension 2014-01-22T21:07:46+11:00 http://pharmadispatch.com/news/new-study-shows-low-vitamin-d-a-risk-for-ms-patients 2014-01-22T21:07:17+11:00 http://pharmadispatch.com/news/englands-cancer-drug-fund-under-pressure 2014-01-23T21:24:28+11:00 http://pharmadispatch.com/news/sanofi-enters-alliance-with-university-of-melbourne 2014-01-23T21:25:16+11:00 http://pharmadispatch.com/news/jj-profit-soars-37-per-cent 2014-01-23T21:23:33+11:00 http://pharmadispatch.com/news/glitpin-price-cut-part-of-a-bastardised-process 2014-01-24T21:00:00+11:00 http://pharmadispatch.com/news/chf-gets-it-wrong-again 2014-01-24T21:00:18+11:00 http://pharmadispatch.com/news/chf-discredits-itself-at-taxpayer-expense 2014-01-24T20:59:47+11:00 http://pharmadispatch.com/news/reinvest-price-disclosure-savings-in-transforming-pharmacy-says- 2014-01-24T20:59:30+11:00 http://pharmadispatch.com/news/industry-questions-pbac-power-on-conditional-recommendations 2014-01-28T21:09:04+11:00 http://pharmadispatch.com/news/when-it-comes-to-pricing-controversy-department-and-ma-agree-on- 2014-01-28T21:09:41+11:00 http://pharmadispatch.com/news/use-medibank-money-for-cancer-drugs-says-walker 2014-01-28T21:08:29+11:00 http://pharmadispatch.com/news/order-of-australia-for-research-australia-chair 2014-01-28T21:07:37+11:00 http://pharmadispatch.com/news/senate-questions-go-quiet-on-pbs 2014-01-28T21:08:10+11:00 http://pharmadispatch.com/news/tga-approves-viivs-new-hiv-therapy 2014-01-29T20:06:56+11:00 http://pharmadispatch.com/news/disappointment-for-pfizer-lung-cancer-drug 2014-01-29T20:04:50+11:00 http://pharmadispatch.com/news/oncology-boosts-bms 2014-01-29T20:01:27+11:00 http://pharmadispatch.com/news/tga-watching-ranbaxy-again 2014-01-29T20:08:50+11:00 http://pharmadispatch.com/news/therapeutic-group-for-dpp-4s 2014-01-29T20:11:51+11:00 http://pharmadispatch.com/news/tpp-progress-slows 2014-01-30T21:06:52+11:00 http://pharmadispatch.com/news/results-pfizer-and-amgen 2014-01-30T21:07:20+11:00 http://pharmadispatch.com/news/uks-nice-says-no-to-societal-benefit-test 2014-01-30T21:07:41+11:00 http://pharmadispatch.com/news/new-leadership-for-chf 2014-01-30T21:07:56+11:00 http://pharmadispatch.com/news/another-government-report-highlights-falling-pbs 2014-01-30T21:07:52+11:00 http://pharmadispatch.com/news/australia-ranks-5th-in-global-ip-index 2014-01-31T21:03:39+11:00 http://pharmadispatch.com/news/pbs-stable-as-other-areas-grow 2014-01-31T21:03:50+11:00 http://pharmadispatch.com/news/what-pharma-patents-review 2014-01-31T21:04:01+11:00 http://pharmadispatch.com/news/company-results-novartis-and-biogen 2014-01-31T21:03:26+11:00 http://pharmadispatch.com/news/investor-pulls-pin-on-the-global-mail 2014-01-31T21:03:16+11:00 http://pharmadispatch.com/news/biogen-welcomes-constructive-pbac-on-ms-drug 2014-02-03T21:03:36+11:00 http://pharmadispatch.com/news/what-game-is-the-ama-playing 2014-02-03T21:04:02+11:00 http://pharmadispatch.com/news/dpp4s-become-a-political-challenge 2014-02-03T21:03:49+11:00 http://pharmadispatch.com/news/save-pbs-to-save-medicare-says-labor 2014-02-03T21:03:24+11:00 http://pharmadispatch.com/news/company-results-lilly-and-celgene 2014-02-03T21:02:56+11:00 http://pharmadispatch.com/news/pharma-sector-gives-half-a-million-to-political-parties 2014-02-04T21:06:01+11:00 http://pharmadispatch.com/news/more-funding-for-pharmacy-says-psa 2014-02-04T21:05:14+11:00 http://pharmadispatch.com/news/local-clinicians-welcome-registration-of-new-ms-treatment 2014-02-04T21:05:36+11:00 http://pharmadispatch.com/news/900mil-slump-in-pbsrpbs-benefits-but-its-not-the-real-story 2014-02-04T21:06:58+11:00 http://pharmadispatch.com/news/ma-further-pricing-reform-will-break-pbs 2014-02-04T21:06:33+11:00 http://pharmadispatch.com/news/ma-stares-down-critics-on-transparency 2014-02-05T21:41:27+11:00 http://pharmadispatch.com/news/pfizer-breast-cancer-drug-hits-endpoint-in-trial 2014-02-05T21:22:19+11:00 http://pharmadispatch.com/news/asmi-backs-vitamin-e-use 2014-02-05T21:24:31+11:00 http://pharmadispatch.com/news/head-office-woes-for-novartis 2014-02-05T21:40:28+11:00 http://pharmadispatch.com/news/la-trobe-surprised-by-harvey-resignation 2014-02-05T21:39:26+11:00 http://pharmadispatch.com/news/gmia-dismisses-grattan-testimony-to-senate-inquiry 2014-02-06T21:31:17+11:00 http://pharmadispatch.com/news/tga-reviews-popular-osteoporosis-drug 2014-02-06T20:40:34+11:00 http://pharmadispatch.com/news/company-results-merck-msd-and-covance 2014-02-06T21:08:51+11:00 http://pharmadispatch.com/news/apps-the-future-of-medicine-management 2014-02-06T21:11:28+11:00 http://pharmadispatch.com/news/halt-all-post-market-reviews-says-ma 2014-02-06T21:31:06+11:00 http://pharmadispatch.com/news/minister-yet-to-decide-fate-of-lsdp-review 2014-02-10T21:05:20+11:00 http://pharmadispatch.com/news/strong-uptake-of-abortion-pill 2014-02-10T21:05:14+11:00 http://pharmadispatch.com/news/listen-to-the-facts-on-vaccinations-urges-nps-medicinewise 2014-02-07T20:32:04+11:00 http://pharmadispatch.com/news/does-the-access-to-medicines-working-group-have-a-future 2014-02-07T20:32:12+11:00 http://pharmadispatch.com/news/dont-take-the-new-zealand-path-warns-ma 2014-02-07T20:31:54+11:00 http://pharmadispatch.com/news/who-is-finance-trying-to-fool 2014-02-10T21:05:09+11:00 http://pharmadispatch.com/news/rule-out-co-pay-increase-demands-labor 2014-02-10T21:04:59+11:00 http://pharmadispatch.com/news/results-astrazeneca-gsk-sanofi 2014-02-10T21:04:55+11:00 http://pharmadispatch.com/news/another-gliptin-letter-as-halton-rejects-ma-reference-pricing-ch 2014-02-10T21:05:38+11:00 http://pharmadispatch.com/news/do-lower-standards-of-evidence-apply-to-price-cuts 2014-02-10T21:05:26+11:00 http://pharmadispatch.com/news/pharmacy-doesnt-like-price-disclosure-but-that-wasnt-always-the- 2014-02-11T20:59:41+11:00 http://pharmadispatch.com/news/patients-send-a-big-message-on-kalydeco 2014-02-11T20:59:31+11:00 http://pharmadispatch.com/news/new-review-finds-wider-health-benefits-from-supplement-use 2014-02-11T20:59:06+11:00 http://pharmadispatch.com/news/someone-else-jumps-on-the-pricing-bandwagon 2014-02-11T20:59:13+11:00 http://pharmadispatch.com/news/pharmacists-flock-to-medadvisor 2014-02-12T20:57:18+11:00 http://pharmadispatch.com/news/seniors-demand-equality-on-immunisation 2014-02-12T20:57:27+11:00 http://pharmadispatch.com/news/nps-generates-savings-but-not-like-price-cuts 2014-02-12T20:57:11+11:00 http://pharmadispatch.com/news/tpp-claims-nonsense-says-robb 2014-02-12T20:57:05+11:00 http://pharmadispatch.com/news/government-defeats-labor-amendments-on-tga-bill-for-now 2014-02-13T20:48:53+11:00 http://pharmadispatch.com/news/labor-mp-launches-parliamentary-attack-on-industry 2014-02-13T20:48:59+11:00 http://pharmadispatch.com/news/a-healthy-and-competitive-commercial-environment-claims-pharmac 2014-02-13T20:48:22+11:00 http://pharmadispatch.com/news/solid-6-months-for-csl 2014-02-13T20:48:18+11:00 http://pharmadispatch.com/news/tga-a-rabbit-warren-says-industry 2014-02-13T20:48:39+11:00 http://pharmadispatch.com/news/guild-takes-control-of-hmrs-and-a-new-incentive-payment-for-phar 2014-02-13T20:48:30+11:00 http://pharmadispatch.com/news/industry-dismisses-mactiernan-claims 2014-02-14T20:57:08+11:00 http://pharmadispatch.com/news/pfizers-atorva-deal-was-not-the-only-one 2014-02-14T20:57:14+11:00 http://pharmadispatch.com/news/accc-case-a-game-changer 2014-02-14T20:57:20+11:00 http://pharmadispatch.com/news/guild-facing-backlash-over-program-caps 2014-02-14T20:56:48+11:00 http://pharmadispatch.com/news/private-market-keeps-growing 2014-02-17T20:26:17+11:00 http://pharmadispatch.com/news/savings-hit-9bn-with-another-4bn-pbs-wipeout 2014-02-17T20:26:44+11:00 http://pharmadispatch.com/news/pbs-forecast-meaningless-in-era-of-big-price-cuts 2014-02-17T20:26:33+11:00 http://pharmadispatch.com/news/medicare-still-growing-as-pbs-slumps 2014-02-17T20:26:24+11:00 http://pharmadispatch.com/news/make-report-public-says-patent-review-panel 2014-02-18T21:06:30+11:00 http://pharmadispatch.com/news/pharma-boost-from-korea-fta 2014-02-18T21:06:22+11:00 http://pharmadispatch.com/news/back-generic-sector-says-gmia 2014-02-18T21:06:36+11:00 http://pharmadispatch.com/news/pbs-price-cut-advocates-take-centre-stage 2014-02-18T21:06:01+11:00 http://pharmadispatch.com/news/calls-for-reform-go-unchallenged 2014-02-19T20:52:10+11:00 http://pharmadispatch.com/news/minister-standing-ground-on-gliptins 2014-02-20T21:08:40+11:00 http://pharmadispatch.com/news/simple-message-winning-the-day 2014-02-19T20:51:50+11:00 http://pharmadispatch.com/news/experts-rebut-tppa-claims 2014-02-19T20:52:00+11:00 http://pharmadispatch.com/news/actavis-to-acquire-forest 2014-02-19T20:51:06+11:00 http://pharmadispatch.com/news/adherence-an-issue-with-adhd 2014-02-20T21:08:17+11:00 http://pharmadispatch.com/news/pharmacy-facing-year-of-reviews 2014-02-21T19:36:31+11:00 http://pharmadispatch.com/news/the-obesity-word-unhelpful-when-it-comes-to-weight-loss 2014-02-20T21:08:27+11:00 http://pharmadispatch.com/news/time-for-change-says-dutton 2014-02-20T21:08:53+11:00 http://pharmadispatch.com/news/the-facts-on-pbs-concessional-category 2014-02-21T19:36:39+11:00 http://pharmadispatch.com/news/minister-nixes-patent-review 2014-02-21T19:36:20+11:00 http://pharmadispatch.com/news/patients-keep-pushing-on-kalydeco 2014-02-24T20:49:06+11:00 http://pharmadispatch.com/news/industry-concern-over-unregistered-comparators 2014-02-24T20:49:22+11:00 http://pharmadispatch.com/news/health-system-gets-sustainability-treatment 2014-02-24T20:49:37+11:00 http://pharmadispatch.com/news/reprieve-for-serviers-protos 2014-02-24T20:49:14+11:00 http://pharmadispatch.com/news/medicare-the-main-cost-driver-in-health 2014-02-24T20:49:45+11:00 http://pharmadispatch.com/news/dispute-over-price-disclosure-distortion 2014-02-25T17:32:58+11:00 http://pharmadispatch.com/news/pbac-recommendations-not-conditional-says-department 2014-02-25T17:33:11+11:00 http://pharmadispatch.com/news/slow-progress-on-tppa 2014-02-25T17:32:39+11:00 http://pharmadispatch.com/news/abbott-joins-health-savings-push 2014-02-26T17:58:14+11:00 http://pharmadispatch.com/news/two-more-chips-fall-in-diabetes-pricing-battle 2014-02-26T17:57:34+11:00 http://pharmadispatch.com/news/health-funds-bypass-pharmacy 2014-02-26T17:57:17+11:00 http://pharmadispatch.com/news/no-deal-signed-in-singapore 2014-02-26T17:57:06+11:00 http://pharmadispatch.com/news/decision-on-lsdp-review-imminent 2014-02-27T18:01:09+11:00 http://pharmadispatch.com/news/tga-backs-ranbaxy-on-quality-for-now 2014-02-27T18:01:00+11:00 http://pharmadispatch.com/news/msd-accepts-gliptin-price-cut 2014-02-27T18:01:22+11:00 http://pharmadispatch.com/news/asmi-urges-caution-on-new-study 2014-02-27T18:00:53+11:00 http://pharmadispatch.com/news/pfizer-direct-sticks-with-dhl 2014-02-28T18:15:27+11:00 http://pharmadispatch.com/news/billions-in-pbs-savings-still-to-come 2014-02-28T18:15:49+11:00 http://pharmadispatch.com/news/nexium-goes-otc 2014-02-28T18:15:18+11:00 http://pharmadispatch.com/news/disclosure-model-opt-out-for-doctors 2014-02-28T18:15:43+11:00 http://pharmadispatch.com/news/new-leadership-team-for-hospira 2014-02-28T18:15:37+11:00 http://pharmadispatch.com/news/new-all-in-one-processor-for-cochlear-implants 2014-03-03T17:54:40+11:00 http://pharmadispatch.com/news/budget-will-be-a-political-challenge-not-just-a-policy-challenge 2014-03-03T17:55:17+11:00 http://pharmadispatch.com/news/gary-phillips-on-transforming-pharmaxis 2014-03-04T17:48:01+11:00 http://pharmadispatch.com/news/could-there-be-another-mou-after-all 2014-03-03T17:55:36+11:00 http://pharmadispatch.com/news/clinicians-and-patients-welcome-new-registrations-and-pbs-listin 2014-03-03T17:54:52+11:00 http://pharmadispatch.com/news/no-savings-from-us-says-guild 2014-03-03T17:54:44+11:00 http://pharmadispatch.com/news/mpa-morning-tea-swamped-by-other-events 2014-03-03T17:55:11+11:00 http://pharmadispatch.com/news/pressure-builds-on-dutton-over-life-saving-drugs 2014-03-03T17:55:04+11:00 http://pharmadispatch.com/news/over-150million-in-savings-from-dpp-4s 2014-03-03T17:55:27+11:00 http://pharmadispatch.com/news/higher-patient-co-pays 2014-03-03T17:54:57+11:00 http://pharmadispatch.com/news/1-october-a-pricing-bloodbath 2014-03-04T17:48:36+11:00 http://pharmadispatch.com/news/swisse-hits-back-over-la-trobe-partnership 2014-03-04T17:48:19+11:00 http://pharmadispatch.com/news/tga-reviews-emergency-contraceptive 2014-03-04T17:48:10+11:00 http://pharmadispatch.com/news/gps-unite-against-pharmacy-push-into-primary-care 2014-03-04T17:48:15+11:00 http://pharmadispatch.com/news/di-natale-demands-transparency-briefing 2014-03-04T17:48:30+11:00 http://pharmadispatch.com/news/mou-2-a-wedge-for-pharmacy 2014-03-05T17:51:17+11:00 http://pharmadispatch.com/news/labor-beefs-up-health-team 2014-03-05T17:50:59+11:00 http://pharmadispatch.com/news/bi-partisan-support-for-rare-disease-patient-registry 2014-03-05T17:51:09+11:00 http://pharmadispatch.com/news/new-xarelto-study-versus-aspirin 2014-03-05T17:51:04+11:00 http://pharmadispatch.com/news/harvey-cancels-retirement 2014-03-05T17:51:13+11:00 http://pharmadispatch.com/news/minister-opens-the-door-to-new-mou 2014-03-05T17:51:22+11:00 http://pharmadispatch.com/news/senate-green-light-for-price-disclosure-changes 2014-03-06T17:55:09+11:00 http://pharmadispatch.com/news/we-need-to-be-sensible-on-mou 2014-03-06T17:55:04+11:00 http://pharmadispatch.com/news/guild-attacks-chemist-warehouse 2014-03-06T17:54:55+11:00 http://pharmadispatch.com/news/private-market-launch-for-novartis-menb-vaccine 2014-03-06T17:54:51+11:00 http://pharmadispatch.com/news/greens-want-clarity-on-lsdp-review 2014-03-06T17:54:59+11:00 http://pharmadispatch.com/news/another-billion-dollar-windfall-on-the-way 2014-03-07T18:04:45+11:00 http://pharmadispatch.com/news/asmi-reassurance-over-vitamin-e 2014-03-07T18:04:37+11:00 http://pharmadispatch.com/news/biotron-shares-soar-on-trial-result 2014-03-07T18:04:25+11:00 http://pharmadispatch.com/news/dutton-set-to-scrap-pbpa-but-industry-rep-for-pbac 2014-03-08T00:19:06+11:00 http://pharmadispatch.com/news/industry-shock-over-scrapping-of-pbpa 2014-03-10T17:59:21+11:00 http://pharmadispatch.com/news/industry-will-miss-pbpa-but-so-will-the-government-eventually 2014-03-10T17:59:17+11:00 http://pharmadispatch.com/news/tga-approves-bayers-stivarga-for-bowel-cancer 2014-03-10T17:59:01+11:00 http://pharmadispatch.com/news/pbac-not-imposing-conditions-seriously 2014-03-10T17:59:06+11:00 http://pharmadispatch.com/news/twittersphere-hit-on-new-lipid-lowering-biologics 2014-03-10T17:58:55+11:00 http://pharmadispatch.com/news/is-pbac-using-conditional-recommendations-to-target-particular-d 2014-03-11T17:57:37+11:00 http://pharmadispatch.com/news/market-prepares-for-viagra-generics 2014-03-11T17:57:20+11:00 http://pharmadispatch.com/news/fewer-health-care-cards-would-mean-fewer-scripts 2014-03-11T17:57:29+11:00 http://pharmadispatch.com/news/malaysias-ihh-mulls-bid-for-healthscope 2014-03-12T18:02:46+11:00 http://pharmadispatch.com/news/ogilvy-recruit-ex-afr-journo 2014-03-12T18:02:39+11:00 http://pharmadispatch.com/news/last-pbpa-meeting-held-by-email 2014-03-12T18:02:58+11:00 http://pharmadispatch.com/news/sigma-backs-medadvisor-compliance-program 2014-03-12T18:02:52+11:00 http://pharmadispatch.com/news/patients-want-intervention-on-kalydeco 2014-03-13T17:52:53+11:00 http://pharmadispatch.com/news/assurances-for-gmia-on-price-increases 2014-03-13T17:52:48+11:00 http://pharmadispatch.com/news/your-calculations-are-wrong-says-dept-and-heres-why 2014-03-13T17:52:41+11:00 http://pharmadispatch.com/news/urgent-change-required-says-crotty 2014-03-13T17:52:58+11:00 http://pharmadispatch.com/news/new-therapies-key-to-improving-treatment 2014-03-18T16:46:12+11:00 http://pharmadispatch.com/news/sector-unites-against-further-reform 2014-03-14T17:48:15+11:00 http://pharmadispatch.com/news/psa-looking-for-new-ceo 2014-03-14T17:48:02+11:00 http://pharmadispatch.com/news/risk-a-natural-part-of-business-says-dutton 2014-03-14T17:48:27+11:00 http://pharmadispatch.com/news/industry-department-silent-on-pbpa 2014-03-14T17:48:08+11:00 http://pharmadispatch.com/news/2-4-billion-in-new-savings-but-is-it-a-last-hurrah 2014-03-17T17:53:26+11:00 http://pharmadispatch.com/news/a-tale-of-two-reports 2014-03-17T17:53:23+11:00 http://pharmadispatch.com/news/focus-on-front-of-shop-urges-asmi 2014-03-17T17:53:08+11:00 http://pharmadispatch.com/news/tolmar-launches-in-home-service 2014-03-17T17:53:02+11:00 http://pharmadispatch.com/news/health-solutions-the-only-way-to-go-as-price-disclosure-hits-pha 2014-03-17T17:53:13+11:00 http://pharmadispatch.com/news/aussies-back-means-testing-and-cuts 2014-03-18T16:46:27+11:00 http://pharmadispatch.com/news/who-says-price-disclosure-doesnt-deliver 2014-03-18T16:46:32+11:00 http://pharmadispatch.com/news/getting-the-forecast-right-is-almost-impossible 2014-03-18T16:46:22+11:00 http://pharmadispatch.com/news/major-parties-close-door-on-lobbyist-reform 2014-03-19T17:43:12+11:00 http://pharmadispatch.com/news/ma-chair-savings-agenda-is-done 2014-03-19T17:43:26+11:00 http://pharmadispatch.com/news/mixed-results-on-lyrica-injunction 2014-03-19T17:43:21+11:00 http://pharmadispatch.com/news/investment-linked-to-pbs-says-shine 2014-03-20T18:10:14+11:00 http://pharmadispatch.com/news/ma-chair-industry-role-in-process-yet-to-be-resolved 2014-03-20T18:09:53+11:00 http://pharmadispatch.com/news/chemmart-doubles-flu-vaccine-service 2014-03-20T18:09:41+11:00 http://pharmadispatch.com/news/asmi-defends-benefits-of-glucosamine 2014-03-20T18:07:49+11:00 http://pharmadispatch.com/news/everyone-taking-credit-for-price-disclosure 2014-03-21T18:02:03+11:00 http://pharmadispatch.com/news/final-report-of-the-patent-review-quietly-appears 2014-03-21T18:02:19+11:00 http://pharmadispatch.com/news/slow-progress-on-clinical-trials-reform 2014-03-21T18:01:53+11:00 http://pharmadispatch.com/news/three-key-findings-of-the-pharmaceutical-patents-review 2014-03-21T18:02:10+11:00 http://pharmadispatch.com/news/aussies-flock-to-non-pbs-medicines 2014-03-24T17:51:20+11:00 http://pharmadispatch.com/news/response-almost-as-quiet-as-reports-release 2014-03-24T17:51:13+11:00 http://pharmadispatch.com/news/the-wrong-people-oversaw-patent-review 2014-03-24T17:51:05+11:00 http://pharmadispatch.com/news/looking-for-another-new-pbac-member 2014-03-24T17:50:57+11:00 http://pharmadispatch.com/news/what-to-make-of-duttons-speech 2014-03-24T17:50:44+11:00 http://pharmadispatch.com/news/parliament-finally-moves-on-trips-protocol 2014-03-24T17:50:36+11:00 http://pharmadispatch.com/news/clinicians-and-patients-cheer-viivs-tivicay 2014-03-25T17:55:28+11:00 http://pharmadispatch.com/news/could-pbac-follow-uk-decision-on-vaccine 2014-03-25T17:55:33+11:00 http://pharmadispatch.com/news/new-formulation-to-cut-opioid-abuse 2014-03-25T17:55:20+11:00 http://pharmadispatch.com/news/pharmacy-condemns-ad 2014-03-25T17:55:14+11:00 http://pharmadispatch.com/news/call-for-action-on-cancer-drug-delays 2014-03-26T17:57:42+11:00 http://pharmadispatch.com/news/new-senate-inquiry-on-health-costs 2014-03-26T17:57:35+11:00 http://pharmadispatch.com/news/switch-to-otc-for-more-savings-says-asmi 2014-03-26T17:57:15+11:00 http://pharmadispatch.com/news/dusc-targets-new-drugs 2014-03-26T17:57:23+11:00 http://pharmadispatch.com/news/houston-we-have-a-problem 2014-03-27T17:20:22+11:00 http://pharmadispatch.com/news/rum-drug-collections-top-540-tonnes 2014-03-27T17:20:07+11:00 http://pharmadispatch.com/news/pbac-chair-is-it-the-time-taken-for-a-decision-or-the-decision-i 2014-03-27T17:20:15+11:00 http://pharmadispatch.com/news/patients-must-make-the-case-for-change 2014-03-28T17:57:00+11:00 http://pharmadispatch.com/news/gps-must-take-control-of-bowel-cancer-screening 2014-03-27T17:19:58+11:00 http://pharmadispatch.com/news/msd-and-pfizer-ink-world-first-dpp-4-diabetes-partnership 2014-03-27T23:24:42+11:00 http://pharmadispatch.com/news/game-playing-adds-to-delays 2014-03-28T17:57:21+11:00 http://pharmadispatch.com/news/sigma-reports-90m-impact-from-price-disclosure 2014-03-28T17:56:48+11:00 http://pharmadispatch.com/news/ama-misunderstood-study-fundings-says-asmi 2014-03-28T17:56:35+11:00 http://pharmadispatch.com/news/clinicians-and-patients-want-action 2014-03-28T17:57:09+11:00 http://pharmadispatch.com/news/pbs-slump-continues 2014-03-31T17:58:35+11:00 http://pharmadispatch.com/news/cut-clinical-trial-red-tape-urges-ma 2014-03-31T17:57:52+11:00 http://pharmadispatch.com/news/di-natale-not-happy-as-transparency-model-hits-legal-hurdles 2014-03-31T17:57:58+11:00 http://pharmadispatch.com/news/policy-needs-to-keep-up-consumer-says-asmi 2014-03-31T17:57:39+11:00 http://pharmadispatch.com/news/tga-confirms-surprise-inspection-of-ranbaxy-facility 2014-03-31T17:58:25+11:00 http://pharmadispatch.com/news/commission-of-audit-boards-and-agencies 2014-04-01T17:58:48+11:00 http://pharmadispatch.com/news/new-cholesterol-busting-biologics-shine-at-acc 2014-04-01T17:59:07+11:00 http://pharmadispatch.com/news/clinicians-welcome-new-remicade-listing 2014-04-01T17:58:58+11:00 http://pharmadispatch.com/news/thats-not-a-cut 2014-04-01T17:59:19+11:00 http://pharmadispatch.com/news/no-going-back-on-generic-pricing 2014-04-02T18:00:39+11:00 http://pharmadispatch.com/news/20-billion-enough-says-ma 2014-04-02T18:00:25+11:00 http://pharmadispatch.com/news/pharmacy-rolls-out-genetic-test 2014-04-02T18:00:05+11:00 http://pharmadispatch.com/news/new-cv-data-for-takedas-nesina 2014-04-02T17:59:46+11:00 http://pharmadispatch.com/news/more-reform-risks-sustainability-says-gmia 2014-04-03T18:01:59+11:00 http://pharmadispatch.com/news/bayer-deploys-xarelto-reps-in-support-of-national-stroke-foundat 2014-04-03T18:04:28+11:00 http://pharmadispatch.com/news/action-needed-on-diabetic-kidney-disease 2014-04-03T18:01:21+11:00 http://pharmadispatch.com/news/whats-that-about-job-losses 2014-04-03T18:01:41+11:00 http://pharmadispatch.com/news/black-box-warning-for-serviers-protos 2014-04-04T17:54:28+11:00 http://pharmadispatch.com/news/mckeon-will-inform-future-policy-says-government 2014-04-04T17:54:14+11:00 http://pharmadispatch.com/news/new-papers-highlight-benefits-of-vitamin-d 2014-04-04T17:53:55+11:00 http://pharmadispatch.com/news/treasury-secretary-targets-health-spending 2014-04-04T17:54:45+11:00 http://pharmadispatch.com/news/for-amgens-prolia-the-timing-was-perfect 2014-04-07T17:57:52+10:00 http://pharmadispatch.com/news/is-pharma-having-a-conversation-with-itself 2014-04-07T17:58:05+10:00 http://pharmadispatch.com/news/sustainability-weve-heard-it-all-before 2014-04-07T18:01:26+10:00 http://pharmadispatch.com/news/will-australia-follow-the-eu-on-clinical-trials-reform 2014-04-07T17:57:42+10:00 http://pharmadispatch.com/news/robb-talks-up-benefits-of-free-trade 2014-04-07T17:57:34+10:00 http://pharmadispatch.com/news/asthma-action-kit-for-pharmacy 2014-04-08T17:57:59+10:00 http://pharmadispatch.com/news/rare-voices-welcomes-tga-collaboration-with-eu 2014-04-08T17:58:28+10:00 http://pharmadispatch.com/news/sun-pharma-acquires-troubled-ranbaxy 2014-04-08T17:58:06+10:00 http://pharmadispatch.com/news/sustainability-on-the-agenda-for-nms-2014 2014-04-08T17:57:49+10:00 http://pharmadispatch.com/news/only-3-in-10-compliance-reviews-found-no-breach-says-tga 2014-04-08T17:58:13+10:00 http://pharmadispatch.com/news/australia-strikes-trade-deal-with-japan 2014-04-08T17:58:20+10:00 http://pharmadispatch.com/news/us-still-unhappy-with-australia 2014-04-10T17:45:30+10:00 http://pharmadispatch.com/news/pharmaxis-partners-with-researchers-on-new-respiratory-device 2014-04-09T18:00:55+10:00 http://pharmadispatch.com/news/not-all-gloom-and-doom-on-manufacturing 2014-04-09T18:01:08+10:00 http://pharmadispatch.com/news/lundbeck-seeks-pbs-listing-for-new-antidepressant 2014-04-09T18:00:43+10:00 http://pharmadispatch.com/news/companies-set-to-fight-us9-billion-actos-verdict 2014-04-09T18:00:28+10:00 http://pharmadispatch.com/news/industry-will-have-to-wait-for-details-of-jaepa 2014-04-09T18:01:19+10:00 http://pharmadispatch.com/news/exclusive-lsdp-review-gets-go-ahead 2014-04-09T18:03:47+10:00 http://pharmadispatch.com/news/patients-welcome-lsdp-review-industry-not-so-sure 2014-04-10T17:45:17+10:00 http://pharmadispatch.com/news/thumbs-down-for-homeopathy 2014-04-10T17:45:12+10:00 http://pharmadispatch.com/news/greens-want-action-on-rx-overdoses 2014-04-10T17:44:53+10:00 http://pharmadispatch.com/news/just-when-you-thought-pharmac-couldnt-get-any-worse 2014-04-11T17:41:35+10:00 http://pharmadispatch.com/news/quality-of-life-added-to-lsdp-review 2014-04-11T17:41:57+10:00 http://pharmadispatch.com/news/training-boost-for-pharmacy-interns 2014-04-11T17:41:17+10:00 http://pharmadispatch.com/news/asmi-backs-new-nhmrc-resource 2014-04-11T17:40:52+10:00 http://pharmadispatch.com/news/where-is-the-money-coming-from 2014-04-11T17:42:10+10:00 http://pharmadispatch.com/news/is-this-finally-progress-on-clinical-trials-reform 2014-04-14T17:52:31+10:00 http://pharmadispatch.com/news/everyone-must-contribute-to-savings-says-hockey 2014-04-14T17:52:45+10:00 http://pharmadispatch.com/news/volume-down-cost-up 2014-04-14T17:52:16+10:00 http://pharmadispatch.com/news/future-growth-will-look-very-different 2014-04-14T17:51:17+10:00 http://pharmadispatch.com/news/tpp-meeting-set-for-may 2014-04-14T17:50:34+10:00 http://pharmadispatch.com/news/action-needed-now-says-ma 2014-04-15T18:10:42+10:00 http://pharmadispatch.com/news/ministers-agree-to-higher-organ-donation-target 2014-04-15T17:53:35+10:00 http://pharmadispatch.com/news/csiro-budget-cuts-a-travesty-says-labor 2014-04-15T17:54:48+10:00 http://pharmadispatch.com/news/nps-urges-families-act-on-antipsychotics-in-elderly 2014-04-15T17:58:29+10:00 http://pharmadispatch.com/news/asset-write-down-for-api 2014-04-15T18:06:13+10:00 http://pharmadispatch.com/news/most-aussies-back-pharmacy-despite-criticism 2014-04-15T18:08:56+10:00 http://pharmadispatch.com/news/another-day-another-attack 2014-04-15T18:07:05+10:00 http://pharmadispatch.com/news/disconnect-over-isds 2014-04-16T17:57:30+10:00 http://pharmadispatch.com/news/delegates-to-vote-at-cpexpo14 2014-04-16T17:55:43+10:00 http://pharmadispatch.com/news/is-the-code-of-conduct-worth-it 2014-04-16T17:57:47+10:00 http://pharmadispatch.com/news/company-results-roche-and-jj 2014-04-16T17:57:14+10:00 http://pharmadispatch.com/news/api-extends-trading-halt 2014-04-17T17:51:12+10:00 http://pharmadispatch.com/news/exclusive-dutton-reinvigorates-access-group 2014-04-17T17:55:55+10:00 http://pharmadispatch.com/news/conflict-of-interest-claims-dismissed 2014-04-17T17:51:31+10:00 http://pharmadispatch.com/news/api-confirms-131-million-impairment 2014-04-17T20:55:41+10:00 http://pharmadispatch.com/news/pfizer-moves-on-az 2014-04-22T18:16:34+10:00 http://pharmadispatch.com/news/impairment-clouds-api-earnings 2014-04-22T17:51:22+10:00 http://pharmadispatch.com/news/company-results-actelion 2014-04-22T17:49:19+10:00 http://pharmadispatch.com/news/private-market-pricing-to-advantage 2014-04-22T18:20:27+10:00 http://pharmadispatch.com/news/quiet-last-hurrah-for-eapd 2014-04-22T17:58:58+10:00 http://pharmadispatch.com/news/valeant-teams-up-with-private-equity-to-pursue-allergan 2014-04-22T18:12:59+10:00 http://pharmadispatch.com/news/wholesalers-could-have-most-to-lose-from-pfizer-takeover-of-az 2014-04-23T17:55:54+10:00 http://pharmadispatch.com/news/industry-concern-over-spd-regulations 2014-04-23T17:56:06+10:00 http://pharmadispatch.com/news/are-budget-rumours-premature-facts 2014-04-23T17:56:24+10:00 http://pharmadispatch.com/news/over-four-million-aussies-vitamin-d-deficient 2014-04-23T17:55:44+10:00 http://pharmadispatch.com/news/novartis-and-gsk-exchange-assets 2014-04-23T03:16:27+10:00 http://pharmadispatch.com/news/catherine-king-on-kalydeco-listing 2014-04-23T17:55:34+10:00 http://pharmadispatch.com/news/cancer-the-focus-of-senate-questions 2014-04-24T17:47:07+10:00 http://pharmadispatch.com/news/cpi-further-evidence-of-price-disclosure-impact-says-shaw 2014-04-24T17:46:54+10:00 http://pharmadispatch.com/news/qrxpharma-slumps-on-fda-rejection-of-moxduo 2014-04-24T17:46:45+10:00 http://pharmadispatch.com/news/company-results-amgen-gilead 2014-04-24T17:46:20+10:00 http://pharmadispatch.com/news/publication-of-march-pbac-outcomes-delayed 2014-04-24T17:47:00+10:00 http://pharmadispatch.com/news/pbs-doesnt-escape-commission-of-audit 2014-04-24T17:47:19+10:00 http://pharmadispatch.com/news/company-results-az-biogen-novartis-lilly-celgene-boehringer-inge 2014-04-28T18:00:09+10:00 http://pharmadispatch.com/news/department-winds-back-chf-funding 2014-04-30T17:59:18+10:00 http://pharmadispatch.com/news/rearguard-budget-action-from-pharma-sector 2014-04-28T18:00:54+10:00 http://pharmadispatch.com/news/gp-co-payment-will-hit-pbs 2014-04-28T18:01:02+10:00 http://pharmadispatch.com/news/dutton-announces-new-listings-2 2014-04-28T18:00:25+10:00 http://pharmadispatch.com/news/dont-attack-dutton-urges-patient-group 2014-04-28T18:00:18+10:00 http://pharmadispatch.com/news/the-dangers-of-monthly-medicare-data 2014-04-28T18:00:33+10:00 http://pharmadispatch.com/news/commission-of-audit-pbs-forecast-is-probably-already-wrong 2014-04-28T18:00:40+10:00 http://pharmadispatch.com/news/pfizer-moving-on-astrazeneca 2014-04-29T17:56:44+10:00 http://pharmadispatch.com/news/patients-demand-dutton-intervene-on-kalydeco 2014-04-29T17:55:58+10:00 http://pharmadispatch.com/news/confusion-over-pbac-outcomes 2014-04-29T17:56:29+10:00 http://pharmadispatch.com/news/managed-entry-listing-for-alexions-soliris 2014-04-29T17:55:42+10:00 http://pharmadispatch.com/news/little-satisfaction-for-cancer-drug-advocates 2014-04-29T17:56:16+10:00 http://pharmadispatch.com/news/anyone-can-get-a-headline-arguing-for-price-cuts 2014-04-29T17:55:26+10:00 http://pharmadispatch.com/news/michael-wonder-takes-a-look-at-the-march-pbac-outcomes 2014-04-30T17:59:25+10:00 http://pharmadispatch.com/news/allergan-seeking-a-white-knight 2014-04-30T17:58:52+10:00 http://pharmadispatch.com/news/company-results-bayer-abbvie-sanofi-merck-co-and-bms 2014-04-30T17:58:36+10:00 http://pharmadispatch.com/news/pharmacy-cutting-back-on-services 2014-04-30T17:59:01+10:00 http://pharmadispatch.com/news/no-everyone-likes-a-price-comparison 2014-05-01T18:00:39+10:00 http://pharmadispatch.com/news/psa-announces-new-committees 2014-05-01T18:00:29+10:00 http://pharmadispatch.com/news/cf-patients-meet-dutton-on-kalydeco 2014-05-01T18:00:50+10:00 http://pharmadispatch.com/news/nothing-to-do-with-us 2014-05-01T18:01:20+10:00 http://pharmadispatch.com/news/industry-mostly-satisfied-with-spd-regulations 2014-05-01T18:01:12+10:00 http://pharmadispatch.com/news/api-reports-68mil-negative-impact-from-price-disclosure 2014-05-01T18:01:01+10:00 http://pharmadispatch.com/news/commission-of-audit-delivers-pbs-doomsday 2014-05-02T01:00:59+10:00 http://pharmadispatch.com/news/consolidate-rd-funding-programs 2014-05-02T01:00:27+10:00 http://pharmadispatch.com/news/pbs-extracts-from-the-national-commission-of-audit-towards-respo 2014-05-02T01:00:48+10:00 http://pharmadispatch.com/news/simplistic-report-reflects-poor-understanding-of-pbs 2014-05-02T01:00:19+10:00 http://pharmadispatch.com/news/recommended-wider-health-system-reforms 2014-05-02T01:00:38+10:00 http://pharmadispatch.com/news/commission-of-audit-friendless 2014-05-02T18:03:13+10:00 http://pharmadispatch.com/news/more-change-speculated 2014-05-02T18:02:04+10:00 http://pharmadispatch.com/news/michael-wonder-breaks-down-the-july-pbac-agenda 2014-05-02T18:03:34+10:00 http://pharmadispatch.com/news/an-undergraduate-and-unimplementable-report 2014-05-02T18:02:25+10:00 http://pharmadispatch.com/news/industry-needs-to-change-says-novogen-ceo 2014-05-05T17:55:52+10:00 http://pharmadispatch.com/news/commission-of-audit-unravels-at-senate-hearing 2014-05-05T17:57:04+10:00 http://pharmadispatch.com/news/wrong-prices-in-report-says-gmia 2014-05-05T17:55:22+10:00 http://pharmadispatch.com/news/az-snubs-latest-pfizer-bid 2014-05-05T17:55:43+10:00 http://pharmadispatch.com/news/dutton-talks-up-industry-investment-ironically 2014-05-05T17:56:07+10:00 http://pharmadispatch.com/news/department-met-head-of-uk-cancer-drugs-fund 2014-05-05T17:55:04+10:00 http://pharmadispatch.com/news/proposed-pbs-entity-could-breach-us-australia-fta 2014-05-05T17:56:53+10:00 http://pharmadispatch.com/news/more-asthmacopd-therapies-on-the-way 2014-05-06T17:55:40+10:00 http://pharmadispatch.com/news/commercial-eyes-working-on-convergence 2014-05-07T17:58:46+10:00 http://pharmadispatch.com/news/medicines-partnership-condemns-commission-of-audit 2014-05-06T17:56:05+10:00 http://pharmadispatch.com/news/pharma-backs-ms-campaign 2014-05-06T17:56:01+10:00 http://pharmadispatch.com/news/stakeholders-back-combination-products-in-asthma 2014-05-06T17:55:54+10:00 http://pharmadispatch.com/news/labor-mp-calls-on-dutton-to-reject-kalydeco-conditions 2014-05-06T17:56:28+10:00 http://pharmadispatch.com/news/new-drug-for-pulmonary-hypertension 2014-05-07T17:58:35+10:00 http://pharmadispatch.com/news/pfizer-bid-could-go-hostile 2014-05-06T17:56:20+10:00 http://pharmadispatch.com/news/labor-hosts-health-roundtable-on-commission-of-audit 2014-05-07T17:59:55+10:00 http://pharmadispatch.com/news/industry-tells-govt-to-steer-clear-of-report 2014-05-07T17:59:17+10:00 http://pharmadispatch.com/news/sanofi-welcomes-listing-of-new-cancer-drug 2014-05-08T18:04:54+10:00 http://pharmadispatch.com/news/new-ma-code-almost-done 2014-05-09T18:07:45+10:00 http://pharmadispatch.com/news/new-zealand-cautions-australia-against-pharmac 2014-05-07T17:59:35+10:00 http://pharmadispatch.com/news/whats-a-broken-promise 2014-05-08T18:11:44+10:00 http://pharmadispatch.com/news/merck-not-interested-in-mega-mergers 2014-05-08T18:05:10+10:00 http://pharmadispatch.com/news/haemophilia-community-welcome-approval-of-alprolix 2014-05-08T18:04:45+10:00 http://pharmadispatch.com/news/new-boss-for-psa 2014-05-08T18:05:19+10:00 http://pharmadispatch.com/news/if-it-aint-broke-well-you-know-how-it-goes 2014-05-08T18:11:33+10:00 http://pharmadispatch.com/news/100-million-lost-in-a-year-from-price-disclosure-says-sigma 2014-05-08T18:05:29+10:00 http://pharmadispatch.com/news/sanofi-launches-diabetes-app 2014-05-09T18:06:18+10:00 http://pharmadispatch.com/news/guild-works-on-clearing-backlog 2014-05-09T18:06:10+10:00 http://pharmadispatch.com/news/industry-reaches-agreement-on-biosimilars 2014-05-09T18:08:43+10:00 http://pharmadispatch.com/news/industry-trepidation-over-first-post-mou-budget 2014-05-12T18:17:11+10:00 http://pharmadispatch.com/news/pfizers-gallagher-urges-government-to-consult 2014-05-12T18:17:02+10:00 http://pharmadispatch.com/news/patients-front-pbac-member-over-kalydeco 2014-05-12T18:16:55+10:00 http://pharmadispatch.com/news/research-australia-awards 2014-05-12T18:16:14+10:00 http://pharmadispatch.com/news/opposition-builds-to-takeover-of-az 2014-05-12T18:16:38+10:00 http://pharmadispatch.com/news/nz-patients-pharmac-at-what-price 2014-05-13T17:45:56+10:00 http://pharmadispatch.com/news/allergan-still-searching-for-a-white-knight 2014-05-12T18:16:24+10:00 http://pharmadispatch.com/news/gsk-payments-disclosure 2014-05-12T18:16:46+10:00 http://pharmadispatch.com/news/study-setback-for-servier-heart-failure-drug 2014-05-12T18:16:31+10:00 http://pharmadispatch.com/news/abc-backdown-on-statin-claims 2014-05-13T17:46:21+10:00 http://pharmadispatch.com/news/what-about-a-fixed-funding-envelope 2014-05-13T17:45:43+10:00 http://pharmadispatch.com/news/what-now-for-asthma-therapies 2014-05-13T17:46:30+10:00 http://pharmadispatch.com/news/positive-results-for-amgen-and-azs-brodalumab 2014-05-13T17:45:27+10:00 http://pharmadispatch.com/news/patients-slugged-to-fund-rd 2014-05-14T17:58:37+10:00 http://pharmadispatch.com/news/government-creates-20-billion-medical-research-fund 2014-05-14T17:58:30+10:00 http://pharmadispatch.com/news/still-contemplating-commission-of-audit 2014-05-14T17:58:19+10:00 http://pharmadispatch.com/news/co-pay-increase-will-boost-private-market 2014-05-14T17:58:44+10:00 http://pharmadispatch.com/news/budget-slugs-patients-to-fund-medical-research-endowment-fund 2014-05-14T06:33:24+10:00 http://pharmadispatch.com/news/mixed-budget-response-from-pharma-sector 2014-05-14T17:59:12+10:00 http://pharmadispatch.com/news/pbs-still-in-decline-as-govt-confirms-9-9bn-in-price-disclosure- 2014-05-14T18:02:56+10:00 http://pharmadispatch.com/news/valeant-bid-for-allergan-gets-nasty 2014-05-15T17:58:28+10:00 http://pharmadispatch.com/news/another-multi-billion-dollar-saving-just-months-away 2014-05-15T17:59:52+10:00 http://pharmadispatch.com/news/researchers-look-beyond-the-politics-on-20bn-fund 2014-05-15T17:59:40+10:00 http://pharmadispatch.com/news/budget-disappointment-for-cancer-drugs 2014-05-15T17:58:44+10:00 http://pharmadispatch.com/news/dutton-defended-pbs-in-budget-discussions 2014-05-16T18:03:43+10:00 http://pharmadispatch.com/news/partner-on-20bn-fund-dutton-tells-industry 2014-05-16T18:03:34+10:00 http://pharmadispatch.com/news/nz-takes-a-different-path-on-health 2014-05-16T18:03:27+10:00 http://pharmadispatch.com/news/gsk-advances-victorian-poppy-trials 2014-05-16T18:03:18+10:00 http://pharmadispatch.com/news/time-for-action-on-clinical-trials 2014-05-19T17:55:08+10:00 http://pharmadispatch.com/news/budget-confirms-pbs-transformation-but-its-not-over 2014-05-19T17:56:14+10:00 http://pharmadispatch.com/news/pbs-revenue-is-the-wildcard-for-growth 2014-05-19T17:55:55+10:00 http://pharmadispatch.com/news/tpp-countries-make-progress-on-pharma-ip 2014-05-19T17:55:33+10:00 http://pharmadispatch.com/news/the-long-journey-to-commercialisation 2014-05-19T17:55:46+10:00 http://pharmadispatch.com/news/uk-wants-more-from-pfizer 2014-05-19T17:55:18+10:00 http://pharmadispatch.com/news/pfizer-makes-final-offer-for-az 2014-05-19T20:39:27+10:00 http://pharmadispatch.com/news/asap-listing-for-breakthrough-drugs-says-lung-foundation 2014-05-20T17:55:28+10:00 http://pharmadispatch.com/news/new-study-to-test-oct-in-diagnosis-of-basal-cell-carcinoma 2014-05-20T17:55:19+10:00 http://pharmadispatch.com/news/courts-backs-pfizer-on-lyrica-injunction 2014-05-20T17:55:36+10:00 http://pharmadispatch.com/news/some-unhappy-az-shareholders 2014-05-20T17:55:46+10:00 http://pharmadispatch.com/news/1-2-billion-in-new-listings-but-3-3-billion-in-price-cuts 2014-05-20T17:56:08+10:00 http://pharmadispatch.com/news/tga-set-to-launch-medicines-shortage-initiative 2014-05-21T18:05:05+10:00 http://pharmadispatch.com/news/what-a-stupid-question 2014-05-20T17:55:59+10:00 http://pharmadispatch.com/news/new-front-opens-in-pbs-diabetes-battle 2014-05-21T18:06:12+10:00 http://pharmadispatch.com/news/dutton-defends-health-budget 2014-05-21T18:05:55+10:00 http://pharmadispatch.com/news/analysts-not-calling-time-on-pfizer-pursuit-of-az 2014-05-21T18:05:15+10:00 http://pharmadispatch.com/news/ma-and-ausbiotech-team-up-for-industry-growth-proposal 2014-05-22T17:44:11+10:00 http://pharmadispatch.com/news/first-meeting-of-new-clinical-trials-reform-group 2014-05-22T17:43:51+10:00 http://pharmadispatch.com/news/no-apotex-branding-in-nps-app 2014-05-22T17:43:21+10:00 http://pharmadispatch.com/news/liberal-senator-criticises-rd-future-fund 2014-05-22T17:43:06+10:00 http://pharmadispatch.com/news/robb-wants-freer-trade 2014-05-23T17:51:32+10:00 http://pharmadispatch.com/news/us-insurers-hit-out-against-drug-pricing 2014-05-23T17:51:21+10:00 http://pharmadispatch.com/news/crotty-hits-back-on-industry-growth-proposal 2014-05-23T17:56:00+10:00 http://pharmadispatch.com/news/diagnosed-with-the-wrong-cancer-say-patients 2014-05-26T17:57:22+10:00 http://pharmadispatch.com/news/gsk-announces-closure-of-melbourne-rd-facility 2014-05-23T22:29:41+10:00 http://pharmadispatch.com/news/the-changing-pbs 2014-05-26T17:59:34+10:00 http://pharmadispatch.com/news/cancer-drugs-the-first-focus-of-latest-review 2014-05-26T17:57:09+10:00 http://pharmadispatch.com/news/not-out-by-too-much-just-3-billion 2014-05-26T17:56:42+10:00 http://pharmadispatch.com/news/we-need-to-talk-about-the-pbs 2014-05-26T17:57:50+10:00 http://pharmadispatch.com/news/ma-looking-for-new-chief-executive 2014-05-26T21:50:54+10:00 http://pharmadispatch.com/news/australian-developed-bowel-cancer-test-set-for-launch 2014-05-27T17:52:40+10:00 http://pharmadispatch.com/news/guild-welcomes-counterfeit-drugs-seizure 2014-05-27T17:53:00+10:00 http://pharmadispatch.com/news/sector-praise-for-departing-ma-chief 2014-05-27T17:53:08+10:00 http://pharmadispatch.com/news/pfizer-concedes-for-now 2014-05-27T17:52:18+10:00 http://pharmadispatch.com/news/consumers-win-as-viagra-goes-generic 2014-05-27T17:53:26+10:00 http://pharmadispatch.com/news/guild-disappointed-at-dutton-response 2014-05-28T17:56:38+10:00 http://pharmadispatch.com/news/new-website-lists-14-current-shortages 2014-05-28T17:54:19+10:00 http://pharmadispatch.com/news/govt-points-to-pbs-in-medicare-debate 2014-05-28T17:57:59+10:00 http://pharmadispatch.com/news/the-myth-of-rising-consumer-health-costs 2014-05-30T17:54:37+10:00 http://pharmadispatch.com/news/40-years-of-funding 2014-05-28T17:57:16+10:00 http://pharmadispatch.com/news/commission-of-audit-is-not-dead-yet 2014-05-29T18:01:40+10:00 http://pharmadispatch.com/news/we-will-respond-in-kind-says-dutton 2014-05-29T18:01:22+10:00 http://pharmadispatch.com/news/valeant-makes-another-move-on-allergan 2014-05-29T18:01:07+10:00 http://pharmadispatch.com/news/industry-executive-appointed-to-ansto-board 2014-05-29T18:00:49+10:00 http://pharmadispatch.com/news/vaccine-doco-wins-health-journalism-award 2014-05-29T18:00:32+10:00 http://pharmadispatch.com/news/govt-set-to-publish-full-pbac-minutes 2014-05-30T17:54:24+10:00 http://pharmadispatch.com/news/diet-essential-for-preventing-macular-degeneration 2014-05-30T17:53:43+10:00 http://pharmadispatch.com/news/best-employer-accreditation-for-bms 2014-05-30T17:53:53+10:00 http://pharmadispatch.com/news/dont-trust-wikipedia-on-health 2014-05-30T17:53:27+10:00 http://pharmadispatch.com/news/targeted-therapies-shine-at-asco 2014-06-02T17:59:05+10:00 http://pharmadispatch.com/news/renewed-speculation-on-halton 2014-06-02T18:02:03+10:00 http://pharmadispatch.com/news/will-you-miss-it-when-its-gone 2014-06-02T17:59:52+10:00 http://pharmadispatch.com/news/ranbaxy-suspends-imports-from-toansa 2014-06-02T18:00:15+10:00 http://pharmadispatch.com/news/apotex-the-new-no-1 2014-06-02T17:59:40+10:00 http://pharmadispatch.com/news/new-reports-focus-on-antipsychotic-use 2014-06-02T17:59:16+10:00 http://pharmadispatch.com/news/medical-research-fund-set-to-fund-clinical-trials 2014-06-03T17:51:45+10:00 http://pharmadispatch.com/news/asco-highlights 2014-06-03T17:51:13+10:00 http://pharmadispatch.com/news/co-pays-and-listings-the-focus-of-senate-estimates 2014-06-03T02:08:59+10:00 http://pharmadispatch.com/news/the-incredible-shrinking-general-category 2014-06-03T17:52:11+10:00 http://pharmadispatch.com/news/tga-defends-actions-on-ranbaxy-toansa 2014-06-03T17:51:28+10:00 http://pharmadispatch.com/news/faster-transfusion-time-for-patients 2014-06-03T17:51:00+10:00 http://pharmadispatch.com/news/continuing-challenges-for-gsk-but-pharma-manufacturing-delivers 2014-06-04T17:50:05+10:00 http://pharmadispatch.com/news/asco-highlights-bms-and-astrazeneca 2014-06-04T17:49:31+10:00 http://pharmadispatch.com/news/nhmrc-ceo-cost-not-an-issue-on-clinical-trials 2014-06-04T17:50:23+10:00 http://pharmadispatch.com/news/crotty-simple-changes-could-drive-investment 2014-06-04T17:50:37+10:00 http://pharmadispatch.com/news/fight-for-allergan-turns-nasty 2014-06-04T17:49:46+10:00 http://pharmadispatch.com/news/industry-leaders-looking-to-divest-older-drugs 2014-06-05T17:59:06+10:00 http://pharmadispatch.com/news/guild-backs-common-sense-on-penalty-rates 2014-06-05T17:59:30+10:00 http://pharmadispatch.com/news/genzyme-still-hopeful-on-myozyme 2014-06-05T18:01:14+10:00 http://pharmadispatch.com/news/asmi-backs-researchers-in-fight-over-supplements 2014-06-05T17:58:53+10:00 http://pharmadispatch.com/news/ma-companies-set-to-approve-new-code 2014-06-06T17:52:26+10:00 http://pharmadispatch.com/news/tpp-in-2015-says-robb 2014-06-06T17:52:39+10:00 http://pharmadispatch.com/news/new-nps-multiple-medicines-website 2014-06-06T17:52:10+10:00 http://pharmadispatch.com/news/tga-drip-feed-on-quality-issues 2014-06-10T17:38:30+10:00 http://pharmadispatch.com/news/industry-wants-new-mou 2014-06-10T17:37:57+10:00 http://pharmadispatch.com/news/transparency-helps-it-doesnt-hinder 2014-06-10T17:38:16+10:00 http://pharmadispatch.com/news/government-snubs-health-sector-for-trade-and-investment-council 2014-06-10T17:36:47+10:00 http://pharmadispatch.com/news/industry-awaits-price-cuts 2014-06-10T17:37:33+10:00 http://pharmadispatch.com/news/merck-spends-us3-85-billion-to-acquire-hep-c-candidate 2014-06-11T17:54:24+10:00 http://pharmadispatch.com/news/allergan-rejects-latest-valeant-takeover-bid 2014-06-11T17:54:39+10:00 http://pharmadispatch.com/news/gmia-we-expect-to-be-involved 2014-06-11T17:54:52+10:00 http://pharmadispatch.com/news/new-ma-code-rules-out-parallel-track 2014-06-11T17:57:23+10:00 http://pharmadispatch.com/news/transparency-model-revealed 2014-06-12T18:03:09+10:00 http://pharmadispatch.com/news/mckeon-backs-concept-of-research-future-fund 2014-06-12T17:57:44+10:00 http://pharmadispatch.com/news/psa-heading-to-paris-and-berlin 2014-06-12T17:57:23+10:00 http://pharmadispatch.com/news/pfizer-cfo-az-bid-failed-because-of-price 2014-06-12T17:57:35+10:00 http://pharmadispatch.com/news/fewer-people-not-filling-scripts-due-to-cost 2014-06-13T17:58:49+10:00 http://pharmadispatch.com/news/victoria-considers-a-wider-role-for-pharmacy 2014-06-13T17:58:19+10:00 http://pharmadispatch.com/news/companies-adopting-wait-and-see-approach-to-abbott-government-sa 2014-06-13T17:58:08+10:00 http://pharmadispatch.com/news/parliamentary-budget-office-identifies-pbs-savings 2014-06-13T17:58:33+10:00 http://pharmadispatch.com/news/department-proposed-pbs-reform-options-to-commission-of-audit 2014-06-13T18:03:46+10:00 http://pharmadispatch.com/news/ma-chief-goes-global 2014-06-16T17:55:20+10:00 http://pharmadispatch.com/news/industry-readies-for-more-reform 2014-06-16T17:55:59+10:00 http://pharmadispatch.com/news/allergan-adopts-poison-pill-defence 2014-06-16T17:55:06+10:00 http://pharmadispatch.com/news/tpp-hits-another-hurdle 2014-06-16T17:54:53+10:00 http://pharmadispatch.com/news/consumers-reject-new-ma-code 2014-06-16T17:55:39+10:00 http://pharmadispatch.com/news/takeovers-not-limited-to-pharma 2014-06-17T17:55:54+10:00 http://pharmadispatch.com/news/drs-should-repay-payments-if-they-withhold-consent-demands-chf 2014-06-17T17:56:30+10:00 http://pharmadispatch.com/news/pharmacy-could-help-boost-falling-immunisation-rates 2014-06-17T17:55:39+10:00 http://pharmadispatch.com/news/model-the-behaviour-you-demand-of-others 2014-06-17T17:56:19+10:00 http://pharmadispatch.com/news/robb-slams-anti-trade-groups 2014-06-17T17:56:06+10:00 http://pharmadispatch.com/news/red-faces-for-valeant-adviser 2014-06-18T17:57:39+10:00 http://pharmadispatch.com/news/guild-launches-its-own-otc-range 2014-06-18T17:56:59+10:00 http://pharmadispatch.com/news/ma-members-endorse-change 2014-06-18T17:58:05+10:00 http://pharmadispatch.com/news/australian-health-system-scores-well-in-international-survey 2014-06-18T17:57:21+10:00 http://pharmadispatch.com/news/coalition-mp-slams-focus-on-medical-research 2014-06-19T17:57:18+10:00 http://pharmadispatch.com/news/one-step-closer-to-higher-pbs-co-pays 2014-06-19T17:56:26+10:00 http://pharmadispatch.com/news/pharmaxis-promotes-success-at-key-european-cf-meeting 2014-06-19T17:56:10+10:00 http://pharmadispatch.com/news/bayer-appoints-new-head-of-nz-pharma-business 2014-06-19T17:55:42+10:00 http://pharmadispatch.com/news/no-pharma-ip-concessions-in-tpp-says-robb 2014-06-19T17:57:53+10:00 http://pharmadispatch.com/news/the-pbs-is-not-what-it-used-to-be 2014-06-20T17:56:31+10:00 http://pharmadispatch.com/news/will-allergan-move-on-shire 2014-06-20T17:56:06+10:00 http://pharmadispatch.com/news/pharma-sleeps-out-for-homeless 2014-06-20T17:55:20+10:00 http://pharmadispatch.com/news/another-billion-dollar-windfall-but-some-drugs-escape-price-cuts 2014-06-20T17:56:51+10:00 http://pharmadispatch.com/news/industry-welcomes-first-meeting-of-new-access-group 2014-06-23T18:03:07+10:00 http://pharmadispatch.com/news/shire-rejects-abbvie-takeover 2014-06-23T18:02:23+10:00 http://pharmadispatch.com/news/the-focus-is-retail-for-apis-priceline-network 2014-06-23T18:02:14+10:00 http://pharmadispatch.com/news/new-ma-120-meal-cap-for-exceptional-circumstances-only 2014-06-23T18:02:37+10:00 http://pharmadispatch.com/news/generics-facing-damages-over-failed-patent-appeal 2014-06-23T18:02:58+10:00 http://pharmadispatch.com/news/deakin-uni-moves-into-medical-education 2014-06-24T17:58:06+10:00 http://pharmadispatch.com/news/tga-monitoring-serviers-ivabradine-after-study-setback 2014-06-24T17:55:37+10:00 http://pharmadispatch.com/news/az-looking-to-boost-pfizer-defence 2014-06-24T17:56:31+10:00 http://pharmadispatch.com/news/lundbeck-reports-positive-results-for-brintellix 2014-06-24T17:55:51+10:00 http://pharmadispatch.com/news/new-program-encourages-pharmacy-to-focus-on-s3 2014-06-24T17:56:09+10:00 http://pharmadispatch.com/news/pbac-fires-early-shot-at-gileads-sovaldi 2014-06-24T17:56:43+10:00 http://pharmadispatch.com/news/shire-deploys-az-defence 2014-06-25T17:41:13+10:00 http://pharmadispatch.com/news/ma-get-on-with-clinical-trials-reform 2014-06-25T17:41:33+10:00 http://pharmadispatch.com/news/new-bionomics-collaboration-with-merck 2014-06-25T17:41:26+10:00 http://pharmadispatch.com/news/bayer-publishes-grants-to-hcos 2014-06-25T17:41:41+10:00 http://pharmadispatch.com/news/allergan-rebuffs-valeant-again 2014-06-25T17:40:59+10:00 http://pharmadispatch.com/news/audit-office-slams-commercialisation-australia-over-500000-grant 2014-06-30T18:00:43+10:00 http://pharmadispatch.com/news/australia-performing-poorly-on-access 2014-06-25T17:41:52+10:00 http://pharmadispatch.com/news/savings-race-towards-20-billion 2014-06-25T17:42:12+10:00 http://pharmadispatch.com/news/government-senator-wants-action-from-alexion 2014-06-26T17:57:01+10:00 http://pharmadispatch.com/news/gp-use-of-medicines-falling 2014-06-26T17:55:34+10:00 http://pharmadispatch.com/news/quilty-the-reality-of-spd-about-to-hit-pharmacy 2014-06-26T17:55:51+10:00 http://pharmadispatch.com/news/bms-melanoma-drug-demonstrates-superior-overall-survival-trial-h 2014-06-26T17:55:17+10:00 http://pharmadispatch.com/news/what-happened-to-the-presumption-of-innocence 2014-06-27T18:00:27+10:00 http://pharmadispatch.com/news/halton-heads-to-finance 2014-06-27T03:00:58+10:00 http://pharmadispatch.com/news/were-waiting-for-a-response-from-government-says-alexion 2014-06-27T18:01:01+10:00 http://pharmadispatch.com/news/medadvisor-tie-up-with-bupa 2014-06-27T17:58:11+10:00 http://pharmadispatch.com/news/asmi-disappointment-over-reform-delay 2014-06-27T17:58:35+10:00 http://pharmadispatch.com/news/pharmaceutical-sector-pays-tribute-to-halton 2014-06-27T17:58:46+10:00 http://pharmadispatch.com/news/medicare-data-hardly-worth-the-trouble 2014-06-27T17:59:05+10:00 http://pharmadispatch.com/news/fewer-than-1-in-10-pbs-scripts-to-general-patients 2014-06-30T18:01:10+10:00 http://pharmadispatch.com/news/company-names-doctor-in-education-event-report 2014-06-30T18:01:27+10:00 http://pharmadispatch.com/news/new-resource-for-hep-b-patients 2014-06-30T18:00:29+10:00 http://pharmadispatch.com/news/mou-expires-with-commission-of-audit-lurking 2014-06-30T18:00:53+10:00 http://pharmadispatch.com/news/takeover-talk-continues 2014-06-30T18:00:17+10:00 http://pharmadispatch.com/news/pharmaxis-bronchitol-nominated-for-prix-galien-award 2014-07-01T17:47:38+10:00 http://pharmadispatch.com/news/recognition-of-a-remarkable-contribution 2014-07-01T17:59:22+10:00 http://pharmadispatch.com/news/novartis-tops-hco-funding-table 2014-07-01T17:59:05+10:00 http://pharmadispatch.com/news/pfizer-tops-consultant-spend 2014-07-01T17:58:08+10:00 http://pharmadispatch.com/news/pharmacy-makes-the-case-at-victorian-inquiry 2014-07-01T17:47:51+10:00 http://pharmadispatch.com/news/sandoz-joins-gmia 2014-07-01T17:58:17+10:00 http://pharmadispatch.com/news/hco-funding-favours-the-new 2014-07-02T17:39:01+10:00 http://pharmadispatch.com/news/cancer-cases-rising-fast 2014-07-02T17:38:12+10:00 http://pharmadispatch.com/news/remember-code-of-ethics-says-psa 2014-07-02T17:38:30+10:00 http://pharmadispatch.com/news/robb-meets-industry-in-switzerland 2014-07-02T17:42:46+10:00 http://pharmadispatch.com/news/sandoz-pleased-to-be-back 2014-07-02T17:37:49+10:00 http://pharmadispatch.com/news/dpp-4-market-takes-a-hit-but-msd-still-dominates 2014-07-03T17:50:07+10:00 http://pharmadispatch.com/news/undermining-the-myths-of-health-spending 2014-07-03T17:48:41+10:00 http://pharmadispatch.com/news/the-authorisation-process-begins 2014-07-03T17:48:06+10:00 http://pharmadispatch.com/news/sector-question-amwg-objectives 2014-07-03T17:49:18+10:00 http://pharmadispatch.com/news/biogen-adds-to-haemophilia-portfolio 2014-07-03T17:48:23+10:00 http://pharmadispatch.com/news/ipn-acquires-pretium 2014-07-03T17:48:56+10:00 http://pharmadispatch.com/news/another-term-for-kardachi-at-psa 2014-07-04T17:51:27+10:00 http://pharmadispatch.com/news/chf-goes-again 2014-07-04T17:53:09+10:00 http://pharmadispatch.com/news/were-falling-behind-says-ma 2014-07-04T17:53:19+10:00 http://pharmadispatch.com/news/more-insight-into-pbac-decisions 2014-07-04T17:53:29+10:00 http://pharmadispatch.com/news/exclusive-company-blames-price-disclosure-for-delistings 2014-07-04T17:54:10+10:00 http://pharmadispatch.com/news/cda-calls-for-change-at-senate-inquiry 2014-07-04T17:54:21+10:00 http://pharmadispatch.com/news/agreement-on-abraxane-now-for-cabinet 2014-07-07T17:31:46+10:00 http://pharmadispatch.com/news/stalemate-on-kalydeco 2014-07-07T17:29:46+10:00 http://pharmadispatch.com/news/were-different-says-chfs-stankevicius 2014-07-07T17:22:10+10:00 http://pharmadispatch.com/news/could-australia-follow-europe-on-eye-drugs 2014-07-09T16:56:01+10:00 http://pharmadispatch.com/news/pharmaxis-enters-trading-halt 2014-07-07T17:17:37+10:00 http://pharmadispatch.com/news/no-significant-growth-for-pharmacy 2014-07-08T17:59:14+10:00 http://pharmadispatch.com/news/review-questions-value-of-insulin-pumps 2014-07-07T17:19:45+10:00 http://pharmadispatch.com/news/dutton-makes-pointed-reference-to-sovaldi 2014-07-08T17:59:30+10:00 http://pharmadispatch.com/news/sanofi-and-janssen-team-up-on-diabetes 2014-07-08T17:59:37+10:00 http://pharmadispatch.com/news/new-study-highlights-long-term-efficacy-of-shires-vyvanse 2014-07-08T17:59:03+10:00 http://pharmadispatch.com/news/co-pay-increases-to-hit-older-australians-finds-study 2014-07-08T17:59:23+10:00 http://pharmadispatch.com/news/financing-setback-for-pharmaxis-puts-global-bronchitol-deal-at-r 2014-07-09T16:55:13+10:00 http://pharmadispatch.com/news/guild-welcomes-changes-to-hiv-testing-and-treatment-access 2014-07-09T16:54:39+10:00 http://pharmadispatch.com/news/allergan-rejects-valeant-board-nominees 2014-07-09T16:35:13+10:00 http://pharmadispatch.com/news/abbvie-raises-bid-for-shire 2014-07-09T16:55:34+10:00 http://pharmadispatch.com/news/qrxpharma-chairman-and-directors-resign 2014-07-10T17:34:18+10:00 http://pharmadispatch.com/news/queensland-extends-pharmacy-vaccination-trial 2014-07-10T17:34:28+10:00 http://pharmadispatch.com/news/gsk-welcomes-addition-to-respiratory-range 2014-07-10T17:34:07+10:00 http://pharmadispatch.com/news/momentum-building-towards-another-mou 2014-07-10T17:43:56+10:00 http://pharmadispatch.com/news/vigilance-required-on-pandemic-preparedness 2014-07-11T17:58:48+10:00 http://pharmadispatch.com/news/another-pbs-windfall-for-government 2014-07-14T17:53:51+10:00 http://pharmadispatch.com/news/new-study-ends-safety-concerns-over-drospirenone 2014-07-11T17:59:04+10:00 http://pharmadispatch.com/news/new-funding-for-diabetes-research 2014-07-11T17:59:21+10:00 http://pharmadispatch.com/news/another-example-of-why-australia-must-avoid-pharmac 2014-07-11T18:12:56+10:00 http://pharmadispatch.com/news/abbvie-in-takeover-talks-with-shire 2014-07-14T17:52:38+10:00 http://pharmadispatch.com/news/coalition-seats-dominate-stroke-rankings 2014-07-14T17:53:43+10:00 http://pharmadispatch.com/news/dutton-comments-offensive-and-utterly-untrue 2014-07-14T17:53:59+10:00 http://pharmadispatch.com/news/two-year-senate-inquiry-on-health 2014-07-14T17:52:51+10:00 http://pharmadispatch.com/news/another-pbac-departure 2014-07-15T17:54:22+10:00 http://pharmadispatch.com/news/asmi-confirms-annual-conference 2014-07-15T17:53:52+10:00 http://pharmadispatch.com/news/parliamentary-researchers-question-need-for-co-pay-increase 2014-07-15T17:54:50+10:00 http://pharmadispatch.com/news/shire-willing-to-back-abbvie-takeover 2014-07-15T17:54:10+10:00 http://pharmadispatch.com/news/cf-patients-back-on-facebook 2014-07-15T17:54:34+10:00 http://pharmadispatch.com/news/cross-party-support-for-soliris 2014-07-16T17:56:38+10:00 http://pharmadispatch.com/news/ip-not-even-discussed-at-canada-meeting 2014-07-16T17:56:08+10:00 http://pharmadispatch.com/news/what-next-for-oxycontin 2014-07-16T17:56:21+10:00 http://pharmadispatch.com/news/link-announces-new-approval 2014-07-16T17:56:00+10:00 http://pharmadispatch.com/news/labor-mp-attacks-industry-again 2014-07-16T17:56:28+10:00 http://pharmadispatch.com/news/gsks-geoff-mcdonald-on-transparency-and-another-mou 2014-07-17T17:56:21+10:00 http://pharmadispatch.com/news/labor-fund-life-saving-drugs-as-quickly-as-possible 2014-07-16T17:56:45+10:00 http://pharmadispatch.com/news/more-delistings-inevitable 2014-07-17T17:56:12+10:00 http://pharmadispatch.com/news/enduring-industry-partnership-for-png 2014-07-18T17:50:12+10:00 http://pharmadispatch.com/news/jj-profit-jumps-on-growing-hepatitis-portfolio 2014-07-17T17:54:31+10:00 http://pharmadispatch.com/news/delay-in-generic-oxycontin 2014-07-17T17:55:50+10:00 http://pharmadispatch.com/news/co-pay-makes-it-through-hor-now-for-the-senate 2014-07-17T17:54:19+10:00 http://pharmadispatch.com/news/cystic-fibrosis-mums-hit-back 2014-07-18T17:50:21+10:00 http://pharmadispatch.com/news/181-new-listings-is-mostly-generics 2014-07-18T17:50:44+10:00 http://pharmadispatch.com/news/dutton-launches-new-asthma-medication-resource 2014-07-18T17:49:53+10:00 http://pharmadispatch.com/news/emerging-markets-and-growth-products-boost-novartis 2014-07-18T17:49:41+10:00 http://pharmadispatch.com/news/abbvie-shire-creates-new-top-10-global-power 2014-07-21T17:48:22+10:00 http://pharmadispatch.com/news/mixed-results-for-australia-in-global-innovation-index 2014-07-21T17:48:12+10:00 http://pharmadispatch.com/news/xenophon-where-is-the-report-you-promised 2014-07-21T17:48:41+10:00 http://pharmadispatch.com/news/social-media-is-changing-everything-for-the-pbs-and-theres-no-go 2014-07-21T17:49:05+10:00 http://pharmadispatch.com/news/parallel-process-starting-to-work 2014-07-21T17:49:01+10:00 http://pharmadispatch.com/news/political-leaders-unite-on-mh17 2014-07-21T17:47:54+10:00 http://pharmadispatch.com/news/jj-teams-up-with-macquarie-university 2014-07-22T17:58:31+10:00 http://pharmadispatch.com/news/new-pharmacy-pain-management-resource 2014-07-22T17:58:10+10:00 http://pharmadispatch.com/news/popular-allergy-treatment-goes-otc 2014-07-22T17:57:59+10:00 http://pharmadispatch.com/news/diabetes-patients-facing-mental-health-challenge 2014-07-22T17:58:58+10:00 http://pharmadispatch.com/news/merck-serono-taps-az-exec-for-md-role 2014-07-22T18:00:08+10:00 http://pharmadispatch.com/news/pbs-listing-for-ranbaxys-nexium-generic 2014-07-22T18:01:14+10:00 http://pharmadispatch.com/news/bms-recognised-in-sustainability-awards 2014-07-23T17:54:59+10:00 http://pharmadispatch.com/news/are-people-arguing-over-something-thats-not-going-to-happen 2014-07-23T17:55:22+10:00 http://pharmadispatch.com/news/pharmacy-gp-tie-up-on-primary-care 2014-07-23T17:55:11+10:00 http://pharmadispatch.com/news/asmi-hits-back-at-criticism-of-complementary-medicines 2014-07-23T17:54:44+10:00 http://pharmadispatch.com/news/new-challenges-on-hiv 2014-07-24T18:05:51+10:00 http://pharmadispatch.com/news/the-cabinet-clock-already-ticking 2014-07-24T18:07:08+10:00 http://pharmadispatch.com/news/submissions-already-making-their-way-to-accc 2014-07-24T18:00:26+10:00 http://pharmadispatch.com/news/uncertainty-surrounds-msac 2014-07-24T18:06:25+10:00 http://pharmadispatch.com/news/prices-keep-falling 2014-07-25T17:44:09+10:00 http://pharmadispatch.com/news/industry-critic-argues-for-regulation 2014-07-25T17:44:00+10:00 http://pharmadispatch.com/news/bi-on-the-offensive-through-social-media 2014-07-25T17:43:38+10:00 http://pharmadispatch.com/news/nonsense-rules-in-tpp-debate 2014-07-28T17:42:17+10:00 http://pharmadispatch.com/news/company-results-biogen-gsk-and-roche 2014-07-25T17:39:06+10:00 http://pharmadispatch.com/news/social-media-debate-not-done-yet 2014-07-28T17:42:05+10:00 http://pharmadispatch.com/news/health-fund-backs-new-bowel-cancer-test 2014-07-28T17:41:47+10:00 http://pharmadispatch.com/news/australia-facing-liver-disease-crisis 2014-07-28T17:41:55+10:00 http://pharmadispatch.com/news/device-technologies-upsizes 2014-07-28T17:41:39+10:00 http://pharmadispatch.com/news/nexium-price-battle-begins 2014-07-29T17:54:51+10:00 http://pharmadispatch.com/news/new-data-confirms-pbs-transformation 2014-07-28T17:42:27+10:00 http://pharmadispatch.com/news/spike-in-pbs-spend-not-what-it-seems 2014-07-28T17:42:35+10:00 http://pharmadispatch.com/news/once-in-a-generation-structural-shift 2014-07-29T17:54:34+10:00 http://pharmadispatch.com/news/additions-to-hospira-leadership-team 2014-07-29T17:54:00+10:00 http://pharmadispatch.com/news/the-shifting-sands-of-the-pbs 2014-07-29T17:54:19+10:00 http://pharmadispatch.com/news/humira-still-delivering-for-abbvie 2014-07-29T17:53:47+10:00 http://pharmadispatch.com/news/department-dismisses-industry-biosimilar-proposal 2014-07-30T18:03:58+10:00 http://pharmadispatch.com/news/another-flawed-analysis-from-grattan 2014-07-30T18:03:46+10:00 http://pharmadispatch.com/news/two-thirds-of-pbac-recommendations-not-listed 2014-07-30T18:03:34+10:00 http://pharmadispatch.com/news/no-need-for-pidg 2014-07-30T18:03:24+10:00 http://pharmadispatch.com/news/company-results-pfizer-merck-co-amgen 2014-07-30T18:03:06+10:00 http://pharmadispatch.com/news/location-rule-comments-lame 2014-07-31T17:55:17+10:00 http://pharmadispatch.com/news/accc-spammed-on-code-authorisation 2014-07-31T17:55:45+10:00 http://pharmadispatch.com/news/improved-result-for-ranbaxy-australia 2014-07-31T17:55:27+10:00 http://pharmadispatch.com/news/perfect-timing-for-az-respiratory-acquisition 2014-07-31T17:55:03+10:00 http://pharmadispatch.com/news/pfizer-to-acquire-baxter-vaccines 2014-07-31T17:53:45+10:00 http://pharmadispatch.com/news/new-help-for-kids-impacted-by-stroke 2014-08-01T17:53:13+10:00 http://pharmadispatch.com/news/ranbaxy-celebrates-launch-of-generic-nexium 2014-08-01T17:53:51+10:00 http://pharmadispatch.com/news/company-results-astrazeneca-and-bayer 2014-08-01T17:54:21+10:00 http://pharmadispatch.com/news/copd-market-set-for-change 2014-08-04T17:55:05+10:00 http://pharmadispatch.com/news/exclusive-global-generics-leader-coming-to-australia 2014-08-01T17:55:40+10:00 http://pharmadispatch.com/news/outcomes-key-for-new-cholesterol-lowering-biologics 2014-08-01T17:54:55+10:00 http://pharmadispatch.com/news/teva-very-serious 2014-08-01T17:55:21+10:00 http://pharmadispatch.com/news/new-global-proposal-for-biosimilar-names 2014-08-04T17:56:30+10:00 http://pharmadispatch.com/news/patience-the-key-for-teva 2014-08-04T17:56:14+10:00 http://pharmadispatch.com/news/allergan-sues-valeant 2014-08-04T17:54:51+10:00 http://pharmadispatch.com/news/dusc-analysis-highlights-the-impact-of-innovation 2014-08-04T17:56:46+10:00 http://pharmadispatch.com/news/change-important-says-department-of-health 2014-08-04T17:56:58+10:00 http://pharmadispatch.com/news/igr-a-bad-omen 2014-08-05T17:59:01+10:00 http://pharmadispatch.com/news/bi-rejects-criticism-over-pradaxa 2014-08-05T17:58:47+10:00 http://pharmadispatch.com/news/treat-code-fines-like-proceeds-of-crime-says-chf 2014-08-05T17:58:35+10:00 http://pharmadispatch.com/news/govt-interested-in-co-pay-proposal 2014-08-05T17:58:19+10:00 http://pharmadispatch.com/news/pharmaxis-sues-novaquest 2014-08-05T17:58:07+10:00 http://pharmadispatch.com/news/does-disclosure-really-require-consent 2014-08-06T17:54:16+10:00 http://pharmadispatch.com/news/department-of-health-rejects-international-comparisons 2014-08-06T17:54:32+10:00 http://pharmadispatch.com/news/industry-sounds-alarm-over-slump-in-exports 2014-08-06T17:54:04+10:00 http://pharmadispatch.com/news/novartis-welcomes-new-copd-therapy-with-private-launch 2014-08-06T17:53:44+10:00 http://pharmadispatch.com/news/dont-stop-taking-pradaxa 2014-08-07T17:54:32+10:00 http://pharmadispatch.com/news/global-role-for-nhmrc-head 2014-08-07T17:54:18+10:00 http://pharmadispatch.com/news/igr-was-wrong-on-pbs-very-wrong-but-right-on-medicare 2014-08-07T17:54:44+10:00 http://pharmadispatch.com/news/a-willingness-to-change-on-cancer-medicines 2014-08-07T17:54:53+10:00 http://pharmadispatch.com/news/pfizer-pbs-constrains-innovation 2014-08-08T18:02:57+10:00 http://pharmadispatch.com/news/new-option-in-ovarian-cancer 2014-08-08T18:02:39+10:00 http://pharmadispatch.com/news/patents-not-papers-says-macfarlane 2014-08-08T18:02:26+10:00 http://pharmadispatch.com/news/allergan-standing-its-ground 2014-08-08T18:02:12+10:00 http://pharmadispatch.com/news/generic-listings-continue-to-dominate 2014-08-11T17:58:48+10:00 http://pharmadispatch.com/news/another-new-brand-in-the-generics-market 2014-08-11T17:59:03+10:00 http://pharmadispatch.com/news/support-for-ma-code 2014-08-11T17:58:56+10:00 http://pharmadispatch.com/news/australia-hits-mylan-result 2014-08-11T17:58:33+10:00 http://pharmadispatch.com/news/payment-shake-up-for-pbs-and-medicare 2014-08-11T17:59:09+10:00 http://pharmadispatch.com/news/psa-seeking-input-on-services 2014-08-11T17:58:16+10:00 http://pharmadispatch.com/news/no-listing-but-an-expanded-indication 2014-08-11T17:58:08+10:00 http://pharmadispatch.com/news/dont-rely-on-ama-chf-tells-government 2014-08-12T17:54:58+10:00 http://pharmadispatch.com/news/why-the-fuss-about-medicare-co-pay 2014-08-12T17:55:20+10:00 http://pharmadispatch.com/news/kalydeco-can-the-stalemate-be-broken 2014-08-12T17:55:11+10:00 http://pharmadispatch.com/news/sanofi-acquires-rights-to-new-inhaled-insulin 2014-08-12T17:54:44+10:00 http://pharmadispatch.com/news/gsk-wants-local-innovators 2014-08-13T18:07:17+10:00 http://pharmadispatch.com/news/govt-analysing-co-pay-options 2014-08-13T18:07:34+10:00 http://pharmadispatch.com/news/court-dismisses-az-crestor-appeal 2014-08-13T18:07:44+10:00 http://pharmadispatch.com/news/could-ma-walk-away-from-authorisation-process 2014-08-13T18:09:36+10:00 http://pharmadispatch.com/news/commission-of-audit-not-going-away 2014-08-13T18:08:15+10:00 http://pharmadispatch.com/news/new-report-highlights-copd-challenge 2014-08-14T17:52:16+10:00 http://pharmadispatch.com/news/nz-shuns-transparency 2014-08-14T17:50:25+10:00 http://pharmadispatch.com/news/healthy-profit-for-csl 2014-08-14T17:49:59+10:00 http://pharmadispatch.com/news/tga-approval-times-accelerating-for-new-drugs 2014-08-14T17:51:01+10:00 http://pharmadispatch.com/news/funding-of-clinical-trials-reforms-underway 2014-08-14T17:50:43+10:00 http://pharmadispatch.com/news/ma-appoints-new-board-member 2014-08-15T17:59:13+10:00 http://pharmadispatch.com/news/qrxpharma-halts-development-of-pain-drug 2014-08-15T17:57:40+10:00 http://pharmadispatch.com/news/no-modelling-on-pbs-safety-net-change 2014-08-15T17:59:27+10:00 http://pharmadispatch.com/news/labor-seizes-heart-foundation-report 2014-08-15T17:56:59+10:00 http://pharmadispatch.com/news/every-day-of-delay-people-die 2014-08-18T17:59:12+10:00 http://pharmadispatch.com/news/is-this-really-the-best-system-in-the-world 2014-08-18T17:59:03+10:00 http://pharmadispatch.com/news/uks-nice-says-yes-to-sovaldi 2014-08-18T17:58:35+10:00 http://pharmadispatch.com/news/medtronic-boss-in-line-for-leadership-award 2014-08-18T17:58:24+10:00 http://pharmadispatch.com/news/problems-mount-for-us-disclosure-model 2014-08-18T17:58:54+10:00 http://pharmadispatch.com/news/chf-wants-ama-proposal 2014-08-18T17:58:47+10:00 http://pharmadispatch.com/news/high-generic-use-claims-nz-but-is-it-really-higher-than-australi 2014-08-19T18:07:11+10:00 http://pharmadispatch.com/news/research-donations-at-risk 2014-08-19T18:07:22+10:00 http://pharmadispatch.com/news/pharma-leaders-on-pollie-pedal 2014-08-19T18:06:58+10:00 http://pharmadispatch.com/news/new-md-for-biogen-idec-australia-nz 2014-08-25T17:56:01+10:00 http://pharmadispatch.com/news/grattan-analysis-unravels-with-time 2014-08-19T18:08:33+10:00 http://pharmadispatch.com/news/only-a-165-million-correction 2014-08-20T17:59:36+10:00 http://pharmadispatch.com/news/doh-no-single-sector-should-carry-reform-burden 2014-08-20T17:59:26+10:00 http://pharmadispatch.com/news/foundation-set-for-new-novartis-building 2014-08-20T17:59:05+10:00 http://pharmadispatch.com/news/guild-launches-national-media-campaign 2014-08-20T17:59:18+10:00 http://pharmadispatch.com/news/a-highly-selective-analysis 2014-08-21T17:53:15+10:00 http://pharmadispatch.com/news/pharmac-funds-new-cancer-medicines-finally 2014-08-21T17:53:01+10:00 http://pharmadispatch.com/news/doh-non-pbs-drugs-driving-higher-consumer-costs 2014-08-21T17:53:28+10:00 http://pharmadispatch.com/news/innovation-centre-for-sanofi 2014-08-21T17:52:47+10:00 http://pharmadispatch.com/news/derision-for-ama-proposal 2014-08-22T17:47:27+10:00 http://pharmadispatch.com/news/bms-and-celgene-partner-in-new-cancer-trial 2014-08-22T17:48:09+10:00 http://pharmadispatch.com/news/changes-at-gmia 2014-08-22T17:49:02+10:00 http://pharmadispatch.com/news/all-eyes-on-hep-c 2014-08-22T17:48:27+10:00 http://pharmadispatch.com/news/pbs-flatlines-over-the-next-decade 2014-08-22T23:23:45+10:00 http://pharmadispatch.com/news/step-therapy-by-stealth 2014-08-25T17:56:12+10:00 http://pharmadispatch.com/news/pbac-buying-time-on-sovaldi 2014-08-25T17:55:53+10:00 http://pharmadispatch.com/news/positives-but-with-price-cuts 2014-08-25T17:56:02+10:00 http://pharmadispatch.com/news/its-all-about-price 2014-08-25T17:56:32+10:00 http://pharmadispatch.com/news/now-its-getting-embarrassing 2014-08-26T17:52:00+10:00 http://pharmadispatch.com/news/debate-ignores-private-market-but-consumers-dont 2014-08-26T17:52:01+10:00 http://pharmadispatch.com/news/continuing-shift-away-from-the-pbs 2014-08-26T17:52:48+10:00 http://pharmadispatch.com/news/new-resource-for-patients-at-risk-of-stroke 2014-08-26T17:52:22+10:00 http://pharmadispatch.com/news/follow-up-analysis-from-maestro 2014-08-26T17:52:11+10:00 http://pharmadispatch.com/news/regrets-over-pbpa 2014-08-27T17:43:55+10:00 http://pharmadispatch.com/news/still-no-clarity-on-msac 2014-08-27T17:43:23+10:00 http://pharmadispatch.com/news/set-responses-only 2014-08-27T17:43:33+10:00 http://pharmadispatch.com/news/new-hope-for-cancer-sufferers 2014-08-27T17:39:01+10:00 http://pharmadispatch.com/news/new-article-for-paul 2014-09-19T01:41:01+10:00 http://pharmadispatch.com/news/-1 2014-09-30T17:37:01+10:00 http://pharmadispatch.com/news/-2 2014-09-30T17:45:01+10:00 http://pharmadispatch.com/news/pharmacist-union-wants-in-on-negotiations 2014-09-30T17:58:01+10:00 http://pharmadispatch.com/news/meng-c-vaccine-recalled 2014-09-30T18:15:01+10:00 http://pharmadispatch.com/news/more-positive-phase-3-data-for-bms-melanoma-therapy 2014-09-30T18:16:01+10:00 http://pharmadispatch.com/news/hri-announces-new-stent-research 2014-09-30T18:17:01+10:00 http://pharmadispatch.com/news/major-parties-back-trips-changes 2014-10-01T17:45:01+10:00 http://pharmadispatch.com/news/department-misses-the-point-on-ma-code 2014-10-01T17:46:01+10:00 http://pharmadispatch.com/news/separate-agreements-in-name-only 2014-10-01T17:47:01+10:00 http://pharmadispatch.com/news/dramatic-day-for-the-pbs 2014-10-01T17:47:01+10:00 http://pharmadispatch.com/news/asmi-nz-leads-the-way-on-rescheduling 2014-10-20T17:51:01+11:00 http://pharmadispatch.com/news/amgen-heads-to-court-on-cholesterol-biologics 2014-10-20T17:53:01+11:00 http://pharmadispatch.com/news/consumer-group-accuses-industry-of-well-everything 2014-10-20T17:53:01+11:00 http://pharmadispatch.com/news/kalydeco-mums-speak-out 2014-10-20T17:54:01+11:00 http://pharmadispatch.com/news/guardian-tops-pharmacy-satisfaction-survey 2014-10-20T17:55:01+11:00 http://pharmadispatch.com/news/accc-signals-need-for-regulatory-reform 2014-10-20T17:56:01+11:00 http://pharmadispatch.com/news/accc-draft-determination-the-detail 2014-10-20T17:56:01+11:00 http://pharmadispatch.com/news/hospitality-the-wildcard 2014-10-20T17:57:01+11:00 http://pharmadispatch.com/news/companies-bidding-for-omega 2014-10-25T21:18:01+11:00 http://pharmadispatch.com/news/abbvie-and-shire-agree-on-merger-termination 2014-10-25T21:20:01+11:00 http://pharmadispatch.com/news/ausbiotech-leader-elected-to-atse 2014-10-25T21:21:01+11:00 http://pharmadispatch.com/news/allergan-hits-back-at-valeant 2014-10-25T21:21:01+11:00 http://pharmadispatch.com/news/new-humira-indication-in-time-for-pbac 2014-10-25T21:23:01+11:00 http://pharmadispatch.com/news/ama-dismisses-nap-evidence 2014-10-25T21:24:01+11:00 http://pharmadispatch.com/news/new-data-confirms-slow-but-increasing-uptake-of-noacs 2014-10-25T21:25:01+11:00 http://pharmadispatch.com/news/we-need-to-be-more-responsive 2014-10-25T21:26:01+11:00 http://pharmadispatch.com/news/labor-mp-backs-kalydeco-listing 2014-10-25T21:26:01+11:00 http://pharmadispatch.com/news/important-debates-obscured-by-absurdities 2014-10-25T21:27:01+11:00 http://pharmadispatch.com/news/pbs-flatlines-as-officials-reveal-real-growth-number 2014-10-25T21:27:01+11:00 http://pharmadispatch.com/news/commercial-eyes-founder-wins-pat-clear-award 2014-10-25T21:28:01+11:00 http://pharmadispatch.com/news/gsk-considers-viiv-ipo 2014-10-25T21:28:01+11:00 http://pharmadispatch.com/news/chemmart-goes-ahead-with-skin-cancer-screening-service 2014-10-25T21:29:01+11:00 http://pharmadispatch.com/news/ama-no-clear-rationale-for-pbs-authorities 2014-10-25T21:29:01+11:00 http://pharmadispatch.com/news/api-revenue-takes-pbs-reform-hit 2014-10-25T21:30:01+11:00 http://pharmadispatch.com/news/pbs-flat-as-a-pancake 2014-10-25T21:30:01+11:00 http://pharmadispatch.com/news/sansom-and-delaat-to-lead-tga-review 2014-10-25T21:32:01+11:00 http://pharmadispatch.com/news/tim-james-the-door-is-open 2014-10-25T22:19:01+11:00 http://pharmadispatch.com/news/patients-thank-minister-for-kalydeco 2014-10-27T19:55:01+11:00 http://pharmadispatch.com/news/results-bms-lilly-and-celgene 2014-10-27T19:56:01+11:00 http://pharmadispatch.com/news/industry-welcomes-tga-review 2014-10-27T19:58:01+11:00 http://pharmadispatch.com/news/consumer-group-gets-it-wrong-very-wrong 2014-10-27T19:58:01+11:00 http://pharmadispatch.com/news/industry-leaders-back-reps 2014-10-27T19:59:01+11:00 http://pharmadispatch.com/news/pbs-criteria-changes-secure-listing-but-vertex-will-pay 2014-10-27T20:00:01+11:00 http://pharmadispatch.com/news/results-merck-co-sanofi-novartis-amgen-and-pfizer 2014-10-29T18:22:01+11:00 http://pharmadispatch.com/news/clinical-genomics-secures-access-to-chinese-market 2014-10-29T18:23:01+11:00 http://pharmadispatch.com/news/pm-urges-medical-researchers-to-get-behind-mrff 2014-10-29T18:24:01+11:00 http://pharmadispatch.com/news/australia-key-for-new-jj-innovation-centre 2014-10-29T18:24:01+11:00 http://pharmadispatch.com/news/merck-co-aims-to-be-global-leader 2014-10-29T18:25:01+11:00 http://pharmadispatch.com/news/-3 2014-10-29T18:25:01+11:00 http://pharmadispatch.com/news/pbs-reform-delivers-one-year-savings-of-13-billion 2014-10-29T18:27:01+11:00 http://pharmadispatch.com/news/government-backs-global-vaccine-initiative 2014-10-31T17:00:01+11:00 http://pharmadispatch.com/news/new-national-asthma-strategy 2014-10-31T17:06:01+11:00 http://pharmadispatch.com/news/another-pbs-indication-for-botox 2014-10-31T17:07:01+11:00 http://pharmadispatch.com/news/ausbiotech-appoints-new-chairman 2014-10-31T17:08:01+11:00 http://pharmadispatch.com/news/ma-slams-vagueness-of-diabetes-review-draft-report 2014-10-31T17:10:01+11:00 http://pharmadispatch.com/news/nap-campaign-disputes-ama-attack 2014-10-31T17:10:01+11:00 http://pharmadispatch.com/news/risk-share-revenue-tops-1billion 2014-10-31T17:12:01+11:00 http://pharmadispatch.com/news/psa-new-model-is-the-future-for-pharmacy 2014-11-03T18:20:01+11:00 http://pharmadispatch.com/news/pfizer-monash-partnership-underway 2014-11-03T18:21:01+11:00 http://pharmadispatch.com/news/novartis-welcomes-copd-listing 2014-11-03T18:24:01+11:00 http://pharmadispatch.com/news/industry-questions-pbac-on-vaccines 2014-11-03T18:31:01+11:00 http://pharmadispatch.com/news/code-defeat-for-high-profile-doctor 2014-11-03T18:32:01+11:00 http://pharmadispatch.com/news/a-pbs-in-transformation 2014-11-03T18:33:01+11:00 http://pharmadispatch.com/news/us-govt-study-backs-pradaxa 2014-11-05T20:56:01+11:00 http://pharmadispatch.com/news/new-study-highlights-shingles-stroke-risk 2014-11-05T20:59:01+11:00 http://pharmadispatch.com/news/psa-health-destination-pilot-boosted-profits 2014-11-05T21:00:01+11:00 http://pharmadispatch.com/news/pic-disbanded-after-gmia-withdraws 2014-11-05T21:02:01+11:00 http://pharmadispatch.com/news/allergan-confirms-potential-white-knight 2014-11-05T21:03:01+11:00 http://pharmadispatch.com/news/pharmaxis-enrols-first-patient-in-pivotal-bronchitol-trial 2014-11-05T21:04:01+11:00 http://pharmadispatch.com/news/low-value-becomes-no-value 2014-11-05T21:08:01+11:00 http://pharmadispatch.com/news/cpa-audit-delayed 2014-11-05T21:10:01+11:00 http://pharmadispatch.com/news/actavis-confirms-acquisition-interest 2014-11-07T21:44:01+11:00 http://pharmadispatch.com/news/research-australia-awards-1 2014-11-07T21:45:01+11:00 http://pharmadispatch.com/news/pharmacy-welcomes-backing-of-major-parties 2014-11-07T21:47:01+11:00 http://pharmadispatch.com/news/generics-facing-lexapro-damages-claim 2014-11-07T21:49:01+11:00 http://pharmadispatch.com/news/gsk-award-recognises-queensland-researcher 2014-11-07T21:54:01+11:00 http://pharmadispatch.com/news/another-lexapro-win-for-lundbeck 2014-11-07T22:00:01+11:00 http://pharmadispatch.com/news/az-reports-higher-revenue 2014-11-07T22:06:01+11:00 http://pharmadispatch.com/news/who-loses-the-plot 2014-11-07T22:08:01+11:00 http://pharmadispatch.com/news/eisai-welcomes-fycompa-listing 2014-11-07T22:10:01+11:00 http://pharmadispatch.com/news/renewed-hope-for-tpp 2014-11-07T22:15:01+11:00 http://pharmadispatch.com/news/-4 2014-11-07T22:39:01+11:00 http://pharmadispatch.com/news/-5 2014-11-08T19:41:01+11:00 http://pharmadispatch.com/news/improving-intellectual-property-underscores-innovation-and-healt 2014-11-09T19:43:01+11:00 http://pharmadispatch.com/news/look-to-history-on-tpp 2014-11-09T19:46:01+11:00 http://pharmadispatch.com/news/doh-modelling 2014-11-09T22:05:01+11:00 http://pharmadispatch.com/news/-6 2014-11-10T00:37:01+11:00 http://pharmadispatch.com/news/allergan-battle-continues 2014-11-10T02:46:01+11:00 http://pharmadispatch.com/news/-7 2014-11-10T22:14:01+11:00 http://pharmadispatch.com/news/pfizer-urges-caution-on-co-payment-changes 2014-11-11T06:11:01+11:00 http://pharmadispatch.com/news/women-feeling-the-stress 2014-11-11T07:27:01+11:00 http://pharmadispatch.com/news/-8 2014-11-11T17:08:01+11:00 http://pharmadispatch.com/news/frances-moves-further-on-avastin-in-macular-degeneration 2014-11-12T13:00:01+11:00 http://pharmadispatch.com/news/pneumonia-still-a-problem-in-australia 2014-11-12T13:00:01+11:00 http://pharmadispatch.com/news/-9 2014-11-12T13:00:01+11:00 http://pharmadispatch.com/news/psa-urges-caution-on-medical-cannabis 2014-11-12T17:26:01+11:00 http://pharmadispatch.com/news/-10 2014-11-13T17:00:01+11:00 http://pharmadispatch.com/news/-11 2014-11-14T17:00:01+11:00 http://pharmadispatch.com/news/-12 2014-11-13T17:00:01+11:00 http://pharmadispatch.com/news/biogen-welcomes-new-ms-approval 2014-11-13T17:00:01+11:00 http://pharmadispatch.com/news/ma-lsdp-review 2014-11-13T17:00:01+11:00 http://pharmadispatch.com/news/tga-review-more-narrow 2014-11-14T05:00:01+11:00 http://pharmadispatch.com/news/diabetics-feeling-bullied 2014-11-13T17:00:01+11:00 http://pharmadispatch.com/news/actavis-in-talks-to-acquire-allergan-for-over-us60-billion 2014-11-13T16:11:01+11:00 http://pharmadispatch.com/news/co-pays-to-hit 2014-11-14T02:48:01+11:00 http://pharmadispatch.com/news/-13 2014-11-14T17:00:01+11:00 http://pharmadispatch.com/news/asmi-tga-review 2014-11-14T19:58:01+11:00 http://pharmadispatch.com/news/cameron-and-abbott-back-new-gsk-manufacturing-investment 2014-11-14T22:21:01+11:00 http://pharmadispatch.com/news/-14 2014-11-14T22:36:01+11:00 http://pharmadispatch.com/news/-15 2014-11-17T03:07:01+11:00 http://pharmadispatch.com/news/-16 2014-11-17T04:53:01+11:00 http://pharmadispatch.com/news/-17 2014-11-17T06:57:01+11:00 http://pharmadispatch.com/news/whose-advocacy-agenda 2014-11-18T17:00:01+11:00 http://pharmadispatch.com/news/chemo-could-be-obsolete-for-advanced-melanoma 2014-11-18T17:00:01+11:00 http://pharmadispatch.com/news/self-care-the-focus-of-asmi-conference 2014-11-18T17:00:01+11:00 http://pharmadispatch.com/news/high-court-backs-bayer-on-yaz-patent 2014-11-18T17:00:01+11:00 http://pharmadispatch.com/news/-18 2014-11-18T17:00:01+11:00 http://pharmadispatch.com/news/pharma-tariff-win-in-china-fta 2014-11-18T17:00:01+11:00 http://pharmadispatch.com/news/nps-wants-urgent-action-on-antibiotics 2014-11-19T17:00:01+11:00 http://pharmadispatch.com/news/high-prices-driving-highest-otc-spend 2014-11-19T17:00:01+11:00 http://pharmadispatch.com/news/ma-welcomes-china-fta 2014-11-19T17:00:01+11:00 http://pharmadispatch.com/news/-19 2014-11-19T17:00:01+11:00 http://pharmadispatch.com/news/-20 2014-11-19T17:00:01+11:00 http://pharmadispatch.com/news/-21 2014-11-19T17:00:01+11:00 http://pharmadispatch.com/news/drug-development-costs-top-us26-billion 2014-11-20T17:00:01+11:00 http://pharmadispatch.com/news/rb-takes-out-asmi-award 2014-11-20T17:00:01+11:00 http://pharmadispatch.com/news/pbac-membership 2014-11-20T17:00:01+11:00 http://pharmadispatch.com/news/-22 2014-11-20T17:00:01+11:00 http://pharmadispatch.com/news/mtaa-calls-for-reform 2014-11-21T17:00:01+11:00 http://pharmadispatch.com/news/bayers-sargent-re-elected-asmi-president 2014-11-21T17:00:01+11:00 http://pharmadispatch.com/news/-23 2014-11-21T17:00:01+11:00 http://pharmadispatch.com/news/-24 2014-11-21T17:00:01+11:00 http://pharmadispatch.com/news/-25 2014-11-21T17:00:01+11:00 http://pharmadispatch.com/news/ma-accepts-accc-condition 2014-11-21T17:00:01+11:00 http://pharmadispatch.com/news/ministers-finally-kill-off-anztpa 2014-11-21T17:00:01+11:00 http://pharmadispatch.com/news/battle-far-from-over 2014-11-24T17:00:01+11:00 http://pharmadispatch.com/news/ldp-senator-swipe-at-minister 2014-11-24T17:00:01+11:00 http://pharmadispatch.com/news/-26 2014-11-24T17:00:01+11:00 http://pharmadispatch.com/news/-27 2014-11-24T17:00:01+11:00 http://pharmadispatch.com/news/-28 2014-11-24T17:00:01+11:00 http://pharmadispatch.com/news/pharmac 2014-11-25T17:00:01+11:00 http://pharmadispatch.com/news/declining-pbs-flattens-health-spending 2014-11-25T17:00:01+11:00 http://pharmadispatch.com/news/award-for-psa-director 2014-11-25T17:00:01+11:00 http://pharmadispatch.com/news/-29 2014-11-25T17:00:01+11:00 http://pharmadispatch.com/news/-30 2014-11-25T17:00:01+11:00 http://pharmadispatch.com/news/trips 2014-11-26T17:00:01+11:00 http://pharmadispatch.com/news/-31 2014-11-26T17:00:01+11:00 http://pharmadispatch.com/news/-32 2014-11-26T17:00:01+11:00 http://pharmadispatch.com/news/new-consumer-rep-for-msac 2014-11-27T17:00:01+11:00 http://pharmadispatch.com/news/-33 2014-11-27T17:00:01+11:00 http://pharmadispatch.com/news/-34 2014-11-27T17:00:01+11:00 http://pharmadispatch.com/news/-35 2014-11-27T17:00:01+11:00 http://pharmadispatch.com/news/-36 2014-11-28T17:00:01+11:00 http://pharmadispatch.com/news/code-of-conduct-conference-day 2014-11-28T17:00:01+11:00 http://pharmadispatch.com/news/pharmacy-backs-victorian 2014-11-28T17:16:01+11:00 http://pharmadispatch.com/news/australian-patients-waiting-too-long-for-life-saving-therapies 2014-11-28T17:00:01+11:00 http://pharmadispatch.com/news/-37 2014-12-01T17:00:01+11:00 http://pharmadispatch.com/news/-38 2014-12-01T17:00:01+11:00 http://pharmadispatch.com/news/-39 2014-12-01T17:00:01+11:00 http://pharmadispatch.com/news/-40 2014-12-01T17:00:01+11:00 http://pharmadispatch.com/news/code 2014-12-01T17:00:01+11:00 http://pharmadispatch.com/news/subtle-change-on-pbs-sustainability 2014-12-02T17:00:01+11:00 http://pharmadispatch.com/news/diabetes 2014-12-02T17:00:01+11:00 http://pharmadispatch.com/news/-41 2014-12-02T17:00:01+11:00 http://pharmadispatch.com/news/watch-for-the-language 2014-12-02T17:00:01+11:00 http://pharmadispatch.com/news/-42 2014-12-03T17:00:01+11:00 http://pharmadispatch.com/news/-43 2014-12-03T17:00:01+11:00 http://pharmadispatch.com/news/-44 2014-12-03T17:00:01+11:00 http://pharmadispatch.com/news/-45 2014-12-03T17:00:01+11:00 http://pharmadispatch.com/news/senate-inquiry-on-cancer-medicines 2014-12-03T17:00:01+11:00 http://pharmadispatch.com/news/why-just-cancer 2014-12-04T17:00:01+11:00 http://pharmadispatch.com/news/sanofi-teams-up-with-sigma-and-diabetes-australia 2014-12-04T17:00:01+11:00 http://pharmadispatch.com/news/queensland-embraces-new-defibrillation-technology 2014-12-04T17:00:01+11:00 http://pharmadispatch.com/news/ma-cautiously-welcomes-senate-inquiry 2014-12-04T17:00:01+11:00 http://pharmadispatch.com/news/-47 2014-12-04T17:00:01+11:00 http://pharmadispatch.com/news/-46 2014-12-05T17:00:01+11:00 http://pharmadispatch.com/news/-48 2014-12-05T17:00:01+11:00 http://pharmadispatch.com/news/accc-extends-the-life-of-edition-17 2014-12-05T17:00:01+11:00 http://pharmadispatch.com/news/time-critical-for-cancer-patients 2014-12-05T17:00:01+11:00 http://pharmadispatch.com/news/-49 2014-12-04T17:03:01+11:00 http://pharmadispatch.com/news/consultation-on-draft-guidelines-for-pca-test 2014-12-05T17:00:01+11:00 http://pharmadispatch.com/news/-50 2014-12-08T17:00:01+11:00 http://pharmadispatch.com/news/-51 2014-12-08T17:00:01+11:00 http://pharmadispatch.com/news/us-based-merck-set-for-another-acquisition 2014-12-08T17:00:01+11:00 http://pharmadispatch.com/news/-52 2014-12-08T17:00:01+11:00 http://pharmadispatch.com/news/dutton-well-be-back-on-co-payments 2014-12-08T17:00:01+11:00 http://pharmadispatch.com/news/-53 2014-12-09T17:00:01+11:00 http://pharmadispatch.com/news/-54 2014-12-09T17:00:01+11:00 http://pharmadispatch.com/news/patent-cases 2014-12-09T17:00:01+11:00 http://pharmadispatch.com/news/-55 2014-12-09T17:00:01+11:00 http://pharmadispatch.com/news/merck-acquires-cubist 2014-12-09T17:21:01+11:00 http://pharmadispatch.com/news/government-sticks-on-pbs-co-pay 2014-12-10T17:00:01+11:00 http://pharmadispatch.com/news/-56 2014-12-10T17:00:01+11:00 http://pharmadispatch.com/news/cancer-drugs-fund 2014-12-10T17:00:01+11:00 http://pharmadispatch.com/news/-57 2014-12-10T17:00:01+11:00 http://pharmadispatch.com/news/pbs-co-pay-delay-looks-like-a-year 2014-12-11T17:00:01+11:00 http://pharmadispatch.com/news/weve-been-saying-the-same-thing-for-years 2014-12-11T17:00:01+11:00 http://pharmadispatch.com/news/layton-leaving-chemmart 2014-12-11T17:00:01+11:00 http://pharmadispatch.com/news/clinicians-welcome-another-hep-c-option 2014-12-11T17:00:01+11:00 http://pharmadispatch.com/news/mercks-cubist-deal-hit-by-patent-loss 2014-12-11T17:00:01+11:00 http://pharmadispatch.com/news/old-criteria-for-new-diabetes-drug-for-now 2014-12-12T17:00:01+11:00 http://pharmadispatch.com/news/takedas-adcetris-boosts-overall-survival 2014-12-12T17:00:01+11:00 http://pharmadispatch.com/news/chf-something-not-right-on-prescribing 2014-12-12T17:00:01+11:00 http://pharmadispatch.com/news/actavis-takes-back-actonel 2014-12-12T17:00:01+11:00 http://pharmadispatch.com/news/government-drops-the-p-word-again 2014-12-15T17:00:01+11:00 http://pharmadispatch.com/news/pharmaceuticals-is-ours-to-manage 2014-12-15T17:00:01+11:00 http://pharmadispatch.com/news/a-sign-of-things-to-come 2014-12-15T17:00:01+11:00 http://pharmadispatch.com/news/patent-cliff-getting-lower 2014-12-15T17:00:01+11:00 http://pharmadispatch.com/news/piwg-loss-a-strategic-blow 2014-12-15T17:00:01+11:00 http://pharmadispatch.com/news/mas-old-transparency-reports 2014-12-15T17:00:01+11:00 http://pharmadispatch.com/news/are-the-days-of-big-downward-revisions-over 2014-12-16T17:00:01+11:00 http://pharmadispatch.com/news/sponsored-medical-graduate-thanks-industry 2014-12-16T17:00:01+11:00 http://pharmadispatch.com/news/piwg-abolition-an-absolute-nonsense 2014-12-16T17:00:01+11:00 http://pharmadispatch.com/news/department-sticks-to-1bn-line-on-sovaldi 2014-12-17T17:00:01+11:00 http://pharmadispatch.com/news/pbs-shifts-to-higher-cost-medicines 2014-12-17T17:00:01+11:00 http://pharmadispatch.com/news/pbac-chair-will-respond-to-misleading-comments 2014-12-18T17:00:01+11:00 http://pharmadispatch.com/news/department-defends-government-on-cancer-medicines 2014-12-17T17:00:01+11:00 http://pharmadispatch.com/news/confirmation-of-new-gmia-ceo 2014-12-17T17:00:01+11:00 http://pharmadispatch.com/news/the-gift-that-keeps-on-giving 2014-12-17T17:00:01+11:00 http://pharmadispatch.com/news/industry-backs-piwg-replacement 2014-12-18T17:00:01+11:00 http://pharmadispatch.com/news/more-backing-for-pharmacist-vaccination 2014-12-18T17:00:01+11:00 http://pharmadispatch.com/news/the-savings-are-still-there-theyre-just-budgeted 2014-12-18T17:00:01+11:00 http://pharmadispatch.com/news/quicker-access-a-priority 2014-12-19T17:00:01+11:00 http://pharmadispatch.com/news/consumer-prices-will-fall-further 2014-12-19T17:00:01+11:00 http://pharmadispatch.com/news/new-report-confirms-importance-of-access 2014-12-19T17:00:01+11:00 http://pharmadispatch.com/news/looking-ahead-to-2015 2014-12-20T19:19:01+11:00 http://pharmadispatch.com/news/repay-us-with-interest 2014-12-22T17:00:01+11:00 http://pharmadispatch.com/news/pbac-scrap-herceptin-program 2014-12-22T17:00:01+11:00 http://pharmadispatch.com/news/recommendation-rate-reveals-little 2014-12-22T17:00:01+11:00 http://pharmadispatch.com/news/new-minister-for-health 2014-12-22T02:15:01+11:00 http://pharmadispatch.com/news/who-is-sussan-ley 2014-12-22T04:35:01+11:00